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Sarah J. Whitcomb, Ph.D.
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It is well established that chromatin is a destination and source for signal transduction
affecting all types of DNA metabolism. Histone proteins in particular are extensively
post-translationally modified (PTM), and many of these individual modifications have
been studied in depth. I have been interested in how the complex repertoire of histone
PTMs are co-regulated to generate combinations with meaningful physiological
outcomes. One important mechanism is “crosstalk” between pre-existing histone PTMs
and enzymes that add or remove subsequent modifications on chromatin. It has been
previously shown that H3 lysine 4 methyltransferases involved in transcriptional
activation are stimulated and repressed by H2Bub and H2Aub, respectively. Here, using
chemically-defined “designer” mononucleosomes, I tested whether nucleosomal
H2BK120ub and H2AK119ub influence the activity of a well-studied histone
methyltransferases complex that is repressive to transcription, Polycomb Repressive
Complex 2 (PRC2). I also built upon previous studies of direct enzymatic crosstalk
between histone ubiquitylation and H3 lysine 79 methyltransferase, Dot1L, by

investigating

the

plasticity

of

ubiquitin

position

in

stimulation

of

Dot1L

methyltransferase activity. Finally, using designer mononucleosomes containing H3
phosphoserine mimetics, crosstalk studies with PRC2 methyltransferase uncovered a
putative novel methyl/phos switch specific to the histone variant H3.3 These studies
address the specificity of crosstalk between pre-existing post-translational modifications
and subsequent methylation, and thereby strengthen our understanding of mechanisms to
establish and maintain functional combinations of histone modifications in chromatin.
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CHAPTER 1: INTRODUCTION
1.1

Chromatin is the physiologically relevant form of eukaryotic genomes
Approximately two meters of DNA need to fit into the nucleus of each human

cell, requiring a compaction level of nearly 10,000 fold (Allis et al., 2007). Despite this
extreme level of compaction (Figure 1.1A), the DNA must remain accessible to the
molecular machinery for critical processes such as DNA replication, transcription, and
DNA repair. Chromatin is evolution’s solution to this so-called “packaging problem.”
Chromatin is an extremely complex composite structure of genomic DNA,
structural proteins, regulatory proteins, and non-coding RNA. Many aspects of chromatin
structure are highly regulated and dynamic in nature, which allows chromatin to meet the
seemingly antagonistic requirements for DNA compaction and accessibility.
The fundamental structural unit in chromatin is the nucleosome: 146 base pairs
(bp) of DNA wrapped 1.65 times around an octamer of histone proteins, two each of
histones H3, H4, H2A and H2B (Kornberg, 1974; Van Holde et al., 1980)(Figure 1.1). In
a landmark paper, Luger, Richmond and colleagues determined the X-ray crystal
structure of the nucleosome at 2.8 A resolution (Luger et al., 1997). This structure, and
other more refined structures that followed (Davey et al., 2002; Schalch et al., 2005)
(Figure 1.1B), has informed innumerable experiments conducted by chromatin biologists,
including those presented in this thesis.
In vivo the nucleosome unit repeats throughout the genome every 160-240 bp
(Van Holde, 1989). Nucleosomes arranged in series, and the linker DNA between them
can, be visualized in electron micrographs of decondensed chromatin to reveal the socalled “beads on a string” structure of nucleosome arrays (Olins and Olins, 1974; Van
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Holde, 1989). A variety of factors regulate progressive compaction of extended
nucleosome arrays into higher and higher order structures, including histone N- and Cterminal “tails” which extend out from the core of the nucleosome particle, linker histone
H1 association, and the recruitment of structural proteins (Hansen, 2002) (Figure 1.1A).
All DNA-templated processes in eukaryotes must navigate the complex chromatin
landscape. Similarly, investigations of these processes must take chromatin as the
physiological form of the genome into account.

1.1.1

Variation and complexity in chromatin
Chromatin is not only an elegant solution to the eukaryotic genome’s packaging

problem, but it is also at the heart of how these organisms index their genome to reflect
cellular memory states and to appropriately respond to the current environment. The
diversity of processes regulated by chromatin is mirrored by the immense structural and
compositional complexity of chromatin itself.

This structural diversity typically

functions by modulating the accessibility of DNA or by recruiting various protein
“effectors” to specific genomic loci. Evolution has generated a battery of mechanisms for
regulated introduction of complexity into chromatin, and a few of these mechanisms will
be highlighted below.
Historically chromatin was characterized as being either heterochromatic or
euchromatic based on microscopic inspection of cytological DNA stains that
differentiated based on local DNA density. Broadly, euchromatin is considered to be
relatively permissive to transcription and its structure is decondensed, whereas
heterochromatin is considered to be highly compacted and transcriptionally silent. The
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regulated incorporation of specific non-histone proteins and non-coding RNA are critical
to the establishment and maintenance of highly compacted chromatin regions (Allis et al.,
2007).
Even mononucleosomes, the minimal repeating units of chromatin, are endowed
with extensive variation. Canonical histones can be replaced with variant versions of
these histones by specific ATP-dependent chromatin remodelers and chaperones.
Although histone variants represent only a minor amount of the total histone pool,
evidence suggests that they have important specialized functions in genome regulation
(Banaszynski et al., 2010; Gamble and Kraus, 2010; Talbert and Henikoff, 2010;
Verdaasdonk and Bloom, 2011). One of the most extensively studied types of variation in
nucleosomes is introduced through enzymatic addition of post-translational modifications
(PTMs) to histone proteins. This important mechanism for chromatin regulation is the
topic of the remainder of this introduction.
All of the above processes to generate structural complexity in chromatin are
dynamic on biological time scales. And most of them are reversible, allowing the same
genome to function differently depending on the precise cellular, developmental, or
environmental context.
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A

B
H3
H4
H2A
H2B

axial view

radial view

Figure 1.1 Nucleosomes are the fundamental repeating unit of chromatin.
A) schematic representation of progressive chromatin fiber compaction in eukaryotic
nuclei, from extended nucleosome arrays into chromatin fibers. Adapted from Hansen
et al. 2002. B) surface rendition of mononucleosome structure, Protein Data Bank code
1KX5. DNA is colored in black and the histones H3, H4, H2A, and H2B are colored
green, lavender, yellow, and orange respectively.
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1.2

Post-translational modification of histones
Post-translational modification of histone proteins takes many chemical forms,

including methylation, acetylation, ubiquitylation, phosphorylation, citrullination, ADPribosylation, sumoylation, and biotinylation among others (Tan et al., 2011). Over the
past 10 years the pace at which histone PTMs have been discovered, mapped and their
functions explored has been remarkable.

1.2.1

General mechanisms of histone PTM function
In general, histone PTMs can be thought of as functioning in cis or in trans

(Figure 1.2).

Modifications that function in cis alter the biophysical properties of

chromatin and directly influence chromatin structure. Those that function in trans
modulate the association or activity of non-histone proteins on chromatin.
Lysine acetylation is a classic example of a histone PTM that can function in cis.
Chromatin is a highly charged polymer as the DNA backbone is negatively charged and
histone proteins are enriched in positively charged side-groups. The especially basic
character of histone tails is understood to neutralize some of the negative charge on the
DNA backbone, allowing for the high degree of chromatin compaction required to fit a
large eukaryotic genome into a nucleus. Further, structural studies of nucleosomes
revealed that the positively charged N-terminal tail of H4 interacts with an acidic surface
on adjacent nucleosomes (Chodaparambil et al., 2007; Dorigo et al., 2003; Luger et al.,
1997). However, acetylation of lysine residues neutralizes the positive charge on the
lysine side chain. This change in the electrostatic properties of histone tails antagonizes
chromatin fiber compaction (Tse et al., 1998). A particularly compelling example of
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reduced chromatin compaction resulting from electrostatic effects has been demonstrated
with nucleosome arrays reconstituted with either H4 acetylated on lysine 16 (H4K16Ac)
or unmodified H4 (Robinson et al., 2008; Shogren-Knaak et al., 2006). Acetylationmediated chromatin decompaction is likely to result in a chromatin template that is more
permissive to transcription (Tse et al., 1998), providing an attractive molecular
mechanism for the long-observed correlation between histone acetylation and
transcription (Allfrey et al., 1964).

A

in cis

effector

B

C

effector

in trans

effector

effector

in trans

Figure 1.2 General mechanisms of histone PTM function. A) post-translational modifications
that function in cis directly influence the propensity of the chromatin fiber to compact or
decompact. Modifications that function in trans modulate either stabilize binding of non-histone
effector proteins on chromatin (B) or inhibit their binding (C).
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Relatively bulky PTMs like ubiquitylation and ADP-ribosylation have also been
proposed to function in cis. Ubiquitylation of H2B on K120 (H2Bub) in particular was
presumed to disrupt nucleosome stacking because of its location on the axial face of the
nucleosome (Davey et al., 2002; Schalch et al., 2005). Very recently, that hypothesis was
validated using nucleosome arrays reconstituted with H2Bub or unmodified octamers
(Fierz et al., 2011). Additionally, H2Bub and H4K16Ac were found to function
synergistically in preventing inter-array interactions, another aspect of chromatin
compaction into higher-order structures (Fierz et al., 2011).
Lysine methylation is the one of the better-studied categories of histone PTMs to
function in trans. The work of many groups has uncovered a handful of distinct methyllysine “reader” domains that are remarkably specific for particular methylation states
(mono, di, trimethyl) and particular methylation sites in histone tails (Taverna et al.,
2007). Perhaps the most famous example is chromodomain-mediated binding of
Heterochromatin Protein 1 (HP1), to histone H3 via methylation on lysine 9 (H3K9me)
(Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002; Jacobs et al., 2001; Lachner et
al., 2001; Nielsen et al., 2002).

H3K9me and HP1 are necessary for proper

heterochromatin maintenance from yeast to multicellular eukaryotes (Eissenberg et al.,
1992; Lorentz et al., 1994), and HP1 can be described as an “effector” protein for H3K9
methylation-mediated heterochromatin formation. The regulation of the HP1/H3K9me
interaction will be discussed further in Chapter 5.
PTMs can also disrupt binding surfaces non-histone proteins. For example,
H4K16Ac prevents binding of the telomere-associated protein Silent Information
Regulator 3 (Sir3) (Armache et al., 2011). In this way H4K16Ac blocks the
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encroachment of heterochromatin into parts of the genome that need to retain
euchromatic characteristics.
In addition to modulating the binding of effector proteins, histone PTMs can
function in trans by allosterically altering the activity of enzymes that act upon
chromatin. This direct enzymatic crosstalk will be the focus of the experiments presented
in this thesis. More specifically, studies of how specific ubiquitylation marks on histones
influence the activity of methyltransferase enzymes on nucleosomal substrates will be
presented. The remainder of Chapter 1 will be dedicated to the relevant
methyltransferases (PRC2 and Dot1L), the methylation marks they transduce
(H3K27me2/3 and H3K79me2/3), and to the two most abundant histone ubiquitylation
sites in mammals (H2AK119ub and H2BK120ub) (Figure 1.3).
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H3K27
H2AK119

H3K79
H2BK120
Figure 1.3 Nucleosome position of H3K27, H3K79, H2BK120, H2AK119.
Surface rendition of mononucleosome structure, Protein Data Bank code 1KX5. DNA is
colored in black and the histones H3, H4, H2A, and H2B are colored green, lavender,
yellow, and orange respectively. Ubiquitylated lysines are colored in red. Methylated
lysines are colored in dark blue.

1.2.2

Histone methylation
Methylation is the covalent transfer of a methyl (-CH3) group. The biological

substrates for methylation are diverse, including lipids, small molecules, nucleic acids as
well as proteins (Walsh, 2006). S-adenosylmethionine (SAM, AdoMet) is the methyl
donor in these reactions. In proteins, methylation occurs on nucleophilic side chains,
especially on nitrogens (N-methylation) and oxygens (O-methylation). Thus far, only Nmethylation has been observed on histone proteins.
Methylation of arginines and lysines in histones has been extensively studied, and
in many cases their regulation has a clear biological outcome and function (Allis et al.,
9	
  

2007). Recently, N-methylation on proline 1 of Drosophila H2B was also reported
(Villar-Garea et al., 2011). Arginines are methylated on their guanidino moiety and can
receive up to two methyl groups. Lysines are methylated on their ε-amine and can accept
up to three methyl groups (Figure 1.4). Methylation of arginine and lysine does not alter
the cationic charge of the side chain but does result in increased hydrophobicity and bulk.
These changes can have a large impact on how histone proteins interact with other
components

of

chromatin,

exemplified

by

the

methylation

state-specific

recruitment/stabilization of histone methylation “readers” (Taverna et al., 2007).

SAM

K

SAH

SAM

SAH

K-me1

SAM

K-me2

SAH

K-me3

)LJXUH0HWK\ODWLRQRIO\VLQHƤ1+2. Adapted from Walsh, 2006. The lysine side chain (K)
can accept up to three methyl groups, resulting in monomethyl-lysine (K-me1), dimethyl-lysine
(K-me2), and trimethyl-lysine (K-me3). N-methyltransferases use S-adenosylmethionine (SAM)
as the methyl donor for these reactions, which is converted into S-adenosylhomocysteine (SAH).

For lysine methyltransferases (MTases), the transformation from unmodified
lysine to trimethylated lysine (me3) is believed to be due to kinetic processivity of the
enzyme, with dimethylation and trimethylation reactions occurring before release of
product from the monomethylation enzymatic cycle (Walsh, 2006). Although lysine side
chains can accept up to three methyl groups, not all methyltransferase enzymes are
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competent to catalyze the addition of three methyl groups on the same lysine. At least in
some cases, the size of the lysine-binding pocket in the methyltransferase can limit which
methylation states can be accepted as substrates (Zhang et al., 2003).
Of the many important histone methylation sites identified to date (Tan et al.,
2011), this thesis will focus on two lysines in histone H3: K27, a classical histone “tail”
PTM, and K79, a solvent exposed residue located in the folded core of H3 (Figure 1.3).

1.2.2.1 SET- mediated methylation of H3K27 by Polycomb Repressive Complex 2
The 130 amino acid SET domain was identified over 15 years ago as a shared
motif between three chromatin associated MTases: SU(VAR)3-9, E(Z), and TRX
(Tschiersch et al., 1994). Subsequent biochemical studies showed that the
methyltransferase activity of these proteins resides in their SET domains. In addition to
these founding Drosophila MTases, SET domains are found in all identified histone
lysine MTases, (except Dot1, which will be discussed in Section 1.2.2.2).
SET domain containing MTases have also been found across much of the tree of
life, from viruses and bacteria, to plants and animals (Qian and Zhou, 2006). Across all
this evolutionary time, the motif critical for catalytic activity, HΦΦNHSC (where Φ is a
hydrophobic residue) has been largely conserved (Rea et al., 2000). In addition to this
catalytic motif, histone methyltransferases contain cysteine-rich domains flanking their
SET domain, and these are also required for catalytic activity. However, plant P. sativum
(pea) and Arabidopsis Rubisco MTases lack cysteine-rich regions but retain catalytic
activity (Klein and Houtz, 1995; Rea et al., 2000), suggesting that these cysteine-rich
regions are important for MTase activity on histones but not for activity per se.
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SET domain histone MTases tend to be inactive on their own, but are active if
found in the presence of their native or reconstituted complexes. Non-catalytic complex
members are often rich in chromatin associated functional domain/motifs. It remains an
active area of research to determine how complex members contribute to the catalytic
activity of SET-domain MTases and how they affect substrate specificity. The SET
domain containing MTase complex of particular relevance to this thesis is Polycomb
Repressive Complex 2 (PRC2).
Members of the Polycomb group (PcG), including components of PRC2, were
originally identified in Drosophila melanogaster as factors necessary to maintain cell-fate
decisions through embryogenesis by repressing Hox genes in a body segment-specific
manner (Kennison, 1995). Biochemical characterization of PcG proteins revealed that
they are structurally and functionally diverse and form large multimeric complexes of
two general types: Polycomb Repressive Complex 1 and 2 (PRC1, PRC2).
In fact, both complexes post-translationally modify histone tails, although the
mechanistic

details

that

may

link

these

activities

remain

unclear.

PRC1

monoubiquitylates H2AK119 (Wang et al., 2004), a modification that will be discussed
in Section 1.2.3, and PRC2 is the methyltransferase complex for H3K27me2/3 (Cao et
al., 2002). Ezh2 is the catalytic subunit of PRC2 and methylates H3 via its SET domain.
One of the initial goals of my thesis work was to explore potential cross-talk relationships
between H2Aub and H3K27me2/3.
SET-domain mediated MTase activity contained in the Ezh2 polypeptide is
required to maintain repression of homeotic genes (Cao et al., 2002; Muller et al., 2002).
These studies were among the first to directly link histone methylation with
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developmentally-regulated gene expression programs. In addition to body patterning and
cellular differentiation programs, Polycomb Repressive Complexes are important for
other cellular memory processes such as stem cell maintenance (Boyer et al., 2006), X
inactivation in female mammals (Heard, 2004), and vernalization in plants (Sung and
Amasino, 2005).

1.2.2.2 Non-SET-mediated methylation of H3K79 by Dot1
Dot1 (disruptor of telomeric silencing-1) was first identified in a S. cerevisiae
screen for genes that disrupt telomeric silencing when overexpressed (Singer et al.,
1998). Approximately 5 years after its initial discovery, several groups independently
discovered that yeast Dot1 (yDot1p) and the mammalian homolog Dot1L (Dot1-Like) are
histone methyltransferases for H3K79 (Feng et al., 2002; Lacoste et al., 2002; Ng et al.,
2002a; van Leeuwen et al., 2002). Knockouts of Dot1 in yeast (van Leeuwen et al.,
2002), flies (Shanower et al., 2005), and mice (Jones et al., 2008) have no detectable
H3K79 methylation, showing Dot1 to be the sole MTase for H3K79 in these organisms.
Dot1 is unique among histone lysine MTases because its catalytic domain is
evolutionarily unrelated to SET domains in all other identified histone lysine MTases. In
fact, the catalytic domain of Dot1 family enzymes is structurally much more similar to
arginine MTases than to histone lysine MTases like Ezh2.
Because over-expression in yeast resulted in de-repression of telomeric regions
(Singer et al., 1998), it was first assumed that Dot1 was involved in heterochromatin
formation. However, deletion of Dot1 also resulted in defective telomeric silencing (van
Leeuwen et al., 2002). Further, H3K79 was found to be hypomethylated in
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heterochromatic domains in yeast (van Leeuwen et al., 2002), and hypermethylated in
euchromatic domains (Ng et al., 2003a), strongly arguing against a direct role for H3K79
methylation in heterochromatin formation.
Telomeric regions are enriched in Sir (silent information regulator) protein
binding. However, in the absence of H3K79 methylation, Sir protein enrichment at
telomeres is lost and their binding titrated out across much larger chromatin domains,
thereby contributing to a breakdown of telomeric heterochromatin (Ng et al., 2002a; van
Leeuwen et al., 2002). A mechanistic explanation for the redistribution of Sir proteins
comes from the observation that methylation of H3K79 prevents Sir3 binding to
chromatin (Altaf et al., 2007). This is an excellent example of a histone PTM acting in cis
to prevent binding an effector protein (Chapter 1.2.1). Further, Dot1 and Sir3 were shown
to compete for the same basic patch on the H4 tail for chromatin-association (Altaf et al.,
2007), thereby contributing to mutually exclusive domains of Dot1/H3K79 methylated
euchromatin and Sir bound heterochromatin. Taken together, these results lead to the
current model whereby Dot1 and K79 methylation are involved in heterochromatinization
indirectly by blocking the spread and “dilution” of heterochromatin-associated proteins
into H3K79 methylated, euchromatic regions of the genome.
In higher eukaryotes, Dot1L activity is also linked to transcriptional regulation. In
Drosophila and mammals, the level of H3K79 methylation correlates well with
transcription level (Okada et al., 2005; Schubeler et al., 2004; Steger et al., 2008). In
actively transcribed genes H3K79 methylation is enriched in the coding region
(Kouskouti and Talianidis, 2005), suggesting a role for Dot1 and H3K79 methylation in
transcriptional elongation. Indeed, H3K79 methylation requires components of the Paf1
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complex (Krogan et al., 2003), which is associated with RNA Pol II during
transcriptional elongation into gene coding regions. However, Paf1 is also required for
ubiquitylation of H2B (H2Bub) in gene coding regions, and H2Bub strongly and directly
stimulates Dot1 MTase activity on chromatin (Chapter 1.2.3.1). Therefore it seems likely
that the requirement of the Paf1 complex for Dot1L MTase activity may be indirect, via
H2Bub.
Dot1-mediated H3K79 methylation is known to function in trans in telomere
maintenance by influencing the binding of effector proteins (see above). However, to
date, H3K79 methylation is not known to influence the binding of proteins involved in
transcriptional regulation. Of course, H3K79 methylation-state sensitive transcriptional
effector proteins may be identified in the future. Interestingly, nucleosomes incorporated
with H3K79me2 have a subtly different local surface contour and electrostatic surface
potential than nucleosomes incorporated with unmodified H3 (Lu et al., 2008). How
H3K79me2-mediated biophysical differences may affect dynamic processes such as
transcription and are intriguing and challenging areas to pursue in Dot1-mediated
H3K79me functional investigations.

1.2.3

Histone ubiquitylation
Ubiquitylation is the covalent addition of the relatively small protein ubiquitin to

target proteins (Figure 1.5). Most eukaryotic proteins are ubiquitylated at some point in
their life cycle, either to modulate the protein’s localization, function or to promote
degradation of the protein. Unlike protein methylation, which occurs in one step,
ubiquitylation requires a three-step enzymatic cascade to effect the formation of an
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isopeptide bond between the C-terminal glycine of ubiquitin and the ε-amino group of a
target lysine side chain (Pickart, 2004) (Figure 1.5B). In the first step, the C-terminal
carboxylate of ubiquitin is activated (“paid for”) by ATP hydrolysis, for ligation by
forming a thioester with a cysteine in an ubiquitin-activating enzyme (E1) (Figure 1.5C).
The activated ubiquityl is then passed from the active site cysteine of E1 to the active site
cysteine of an ubiquitin-conjugating enzyme (E2) in an energy-neutral thioester exchange
(transthiolation) (Figure 1.5D). Finally, an ubiquitin-ligase (E3) facilitates the transfer of
activated ubiquityl from the E2 to the lysine amino group on the target protein (Figure
1.5E). The majority of E3 ubiquitin-ligases contain a RING domain that contains both E2
binding and ubiquitin transfer activity (Deshaies and Joazeiro, 2009). Ubiquitylation-site
specificity is determined by the E2/E3 pair, whose three-dimensional structures contain
recognition elements to select protein lysine acceptors for ubiquitin. Given this, it is
perhaps not surprising that humans have ~ 600 E3s, ~40 E2s, but only two E1 enzymes
(Chen and Sun, 2009). Like many other PTMs, ubiquitylation is a reversible
modification. The human proteome contains ~ 90 ubiquitin-specific isopeptidases, called
deubiquitylating enzymes (DUBs)(Chen and Sun, 2009). As will be discussed below,
cycles of ubiquitylation and deubiquitylation on the same histone lysine are implicated in
transcriptional regulation.
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Figure 1.5 Ubiquitylation enzymatic machinery. Adapted from Walsh, 2006. A)
ribbon diagram of the 3-dimensional fold of ubiquitin, Protein Data Bank code 1UBQ.
Ubiquitin is a relatively small protein of 76 amino acids, approximately 8.5 kDa. B)
ubiquitylation of lysine ε-NH2 requires the hydrolysis of ATP and the stepwise action of
a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a
ubiquitin-ligase (E3). C) activation of ubiquitin for ligation. D) transfer of the activated
ubiquityl from the active-site cysteine of E1 to the active-site cysteine of E2. E) E3
mediated transfer of ubiquityl from E2 to the lysine amino group in the target protein.
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In addition to monoubiquitylation of target protein lysine side chains, lysines in
ubiquitin itself can be ubiquitylated, resulting in the formation of ubiquitin chains linked
by isopeptide bonds. It is becoming clear that chains of different architectures and of
different lengths are interpreted differently by the cell and result in different outcomes for
the ubiquitylated protein (Ikeda and Dikic, 2008).
Although best known as a proteomic degradation signal, ubiquitylation (especially
monoubiquitylation) also functions as a reversible signal to regulate protein localization
and activity (Chen and Sun, 2009; Schnell and Hicke, 2003). In addition to its welldescribed roles in vesicle trafficking and transmembrane receptor localization,
monoubiquitylation is crucial for chromatin mediated processes such DNA damage
response (DDR) (Al-Hakim et al., 2010) and transcriptional regulation (Weake and
Workman, 2008).
In mammalian cells 5-15% of H2A is monoubiquitylated at lysine 119 (K119)
(Goldknopf and Busch, 1977; West and Bonner, 1980) and approximately 1% of H2B is
ubiquitylated at K120 (West and Bonner, 1980). Other less abundant ubiquitylation sites
in mammalian histones include H2BK125 (Minsky and Oren, 2004), H2BK34 (Wu et al.,
2011), and H4K91 (Yan et al., 2009).
There is no evidence I know of that ubiquitylated histones are degraded more
rapidly than their non-ubiquitylated counterparts, supporting the notion that histonemonoubiquitylation plays a chromatin regulatory role rather than functions as a
degradative signal. Although steady-state levels of histone-monoubiquitylation are high
(especially H2Aub), the ubiquitin moieties themselves on histones are rapidly turned over
(Seale, 1981; Wu et al., 1981). Histone ubiquitylation levels are therefore tunable by
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modulating the activity of either E2/E3 pairs or DUBs for a particular ubiquitylation site,
which will rapidly increase or decrease of the ubiquitylation level. How the dynamic
nature of histone monoubiquitylation contributes to the chromatin regulatory functions of
H2Aub and H2Bub is an active area of investigation.
Evidence acquired to date support histone ubiquitylation functioning both in cis
and in trans. Relative to other histone PTMs, monoubiquitylation is quite bulky (e.g.
~200x larger than trimethylation), and consequently it has long been thought to influence
chromatin structure in cis through steric effects (Robzyk et al., 2000). This hypothesis
was supported by the observation that histone ubiquitylation is lost during the final stage
of chromosome condensation during mitosis and reappears shortly after cytokinesis as
chromosomes decondense (Mueller et al., 1985; Wu et al., 1981). A significantly more
direct biophysical study of ubiquitylated nucleosomal array compaction will be discussed
below (Fierz et al., 2011).
Like other histone PTMs, histone ubiquitylation may function in trans by
recruiting or stabilizing the binding of an effector protein on chromatin, thereby
translating the histone PTM into specific functional outcomes. The three-dimensional
fold of ubiquitin is recognized by at least 20 structurally distinct ubiquitin binding
domains (UBD), some of which are found in chromatin proteins involved in DNA
damage response and transcriptional regulation (Chen and Sun, 2009). Typically, UBDUb binding is relatively weak, ranging from several micromolar to several millimolar,
suggesting that additional contacts between the UBD containing protein and the
ubiquitylated protein are important for sufficient affinity as well as specificity (Chen and
Sun, 2009).
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Histone ubiquitylation can also function by modulating the activity of other
enzymes on chromatin, such as proteins that post-translationally modify histones. Several
documented cases of crosstalk between histone ubiquitylation and histone methylation
will be described below.

1.2.3.1 Functions of H2BK120ub
H2Bub was first strongly associated with active transcription in the ciliate
Tetrahymena thermophila (Nickel et al., 1989). This organism physically partitions its
genome into two distinct nuclei, one transcriptionally active and the other
transcriptionally silent. After careful fractionation of these two types of nuclei, H2Bub
was shown to be strongly enriched in the transcriptionally active macronucleus relative to
the transcriptionally silent micronucleus (Nickel et al., 1989). Genetic studies in yeast
also supported a role of H2Bub in transcriptional activation, especially the elongation
step (Henry et al., 2003; Pavri et al., 2006; Tanny et al., 2007; Xiao et al., 2005).
Genome-wide chromatin immunoprecipitation (ChIP) studies have mapped H2Bub levels
and locations in human cells and found H2Bub in the coding regions of highly expressed
genes (Minsky et al., 2008).
The E2/E3 pair for H2Bub is Rad6/Bre1 (Kim et al., 2009; Kim et al., 2005; Zhu
et al., 2005). For proper chromatin recruitment, these polypeptides require association
with the transcriptional elongation complex, Paf1 (Ng et al., 2003b; Wood et al., 2003),
which is believed to carry the ubiquitylation machinery into the coding region of the
gene. Importantly, this association establishes a physical link between the H2B
ubiquitylation machinery and transcription machinery (Kim and Roeder, 2009).
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However, in the past few years our understanding of the link between
ubiquitylation of H2B and active transcription has grown more complicated. Intriguingly,
optimal transcription, at least for some genes, requires cycles of ubiquitylation and
deubiquitylation in gene bodies (Daniel et al., 2004; Henry et al., 2003; Wyce et al.,
2007). Depletion of the E3 for H2BK120 and near abolishment of H2Bub does not
significantly alter the expression level of most genes, and contrary to expectation, of
those with altered expression, about equal numbers are activated and suppressed by the
H2Bub E3 ligase RNF20/Bre1A (Batta et al., 2011; Shema et al., 2008). Further,
although steady-state H2Bub level correlates genome-wide with expression level
(Minsky et al., 2008), genes suppressed by RNF20 were found to be associated with
higher levels of H2Bub than genes activated by RNF20 (Shema et al., 2008). In yeast as
well there is at least one report linking H2Bub to transcriptional repression of
euchromatic genes (Turner et al., 2002). These data raise the possibility that H2Bub may
be involved in transcriptional repression in some chromatin contexts.
One possibility is that the position of H2Bub within a gene may influence how
H2Bub is “read”. Schulze and colleagues found H2Bub enrichment in gene bodies
correlates with active transcription while enrichment at promoters is correlated with
repression (Schulze et al., 2011). The authors combined multiple existing hypotheses for
H2Bub function and proposed two roles dependent on genomic location: 1) H2Bub
within the coding region positively regulates transcriptional elongation by promoting
nucleosome reformation after RNA Pol II passes through (Fleming et al., 2008), while in
contrast, 2) H2Bub in the promoter region negatively regulates transcription initiation by
inhibition of nucleosome displacement (Chandrasekharan et al., 2009), which in turn
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poses a physical barrier to the transcriptional machinery. Therefore at promoters H2Bub
may participate in keeping lowly transcribed genes “off”.
Due to ubiquitin’s relative bulk and the location of the major H2B ubiquitylation
site on the axial face of the nucleosome (Figure 1.3), H2Bub has long been proposed to
facilitate transcription by serving as a wedge between adjacent nucleosomes and thereby
preventing the formation of compacted chromatin structures (Robzyk et al., 2000; Sun
and Allis, 2002). Further, determination of the tetranucleosome structure supported the
notion that H2B ubiquitylation would be incompatible with compaction of nucleosome
arrays (Schalch et al., 2005).
This “wedge” hypothesis was recently tested using chemically-defined
nucleosomal arrays, i.e. “designer chromatin” (Section 1.2.4). At ion concentrations in
the physiological range, nucleosome arrays assembled from unmodified octamers
compact into helical structures of approximately 30 nm in diameter. However, arrays
assembled from designer octamers containing H2Bub were relatively resistant to intraarray compaction and inter-array association (Fierz et al., 2011). Interestingly, the
relative resistance to compaction of H2Bub arrays is not simply a function of ubiquitin’s
bulk. Hub1, an ubiquitin like protein of similar size and fold to ubiquitin does not prevent
compaction in these assays (Fierz et al., 2011). This suggests that there is something
about the precise fold of ubiquitin and its interaction with the nucleosomal surface that
mediates the observed resistance to compaction of H2Bub nucleosomal arrays.
However, the most dramatic known effect of H2Bub in chromatin is its crosstalk
with methylation of H3K4 and H3K79, both strongly implicated in transcriptional
regulation. From yeast to humans, H2Bub is genetically upstream of H3K4 and H3K79
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methylation (Briggs et al., 2002; Dover et al., 2002; Ng et al., 2002b; Sun and Allis,
2002), and in vitro H2Bub directly stimulates their MTases Set1 (Kim et al., 2009) and
Dot1L (McGinty et al., 2008) respectively. Notably, Set1 and Dot1L are evolutionarily
unrelated MTases, raising the question how does H2Bub stimulate both of the enzymes?
This and related questions of crosstalk specificity will be addressed in subsequent
chapters.

1.2.3.2 Functions of H2AK119ub
H2A was the first ubiquitylated protein identified, more than 30 years ago
(Goldknopf and Busch, 1977; Hunt and Dayhoff, 1977). Despite this relatively long
research record, and the abundance of this modification in chromatin (5-15% in
mammalian cells), the function of H2Aub is still enigmatic.
H2Aub was initially linked to active transcription in Drosophila and mouse cell
culture. Using biochemical chromatin fractionation and 2D-gel analysis, two groups
determined that ubiquitylated mononucleosomes co-migrated with mononucleosomes
from transcriptionally active (Barsoum and Varshavsky, 1985; Huang et al., 1986) and
poised (Levinger and Varshavsky, 1982) loci. However, using a similar experimental
system, co-migration was retained upon isopeptidase treatment, arguing that nucleosomes
from these transcribed genes were not in fact ubiquitylated (Huang et al., 1986). The link
between H2Aub and active transcription is also not supported globally, as H2Aub is not
enriched in transcriptionally active or inactive chromatin pools (Dawson et al., 1991).
Subsequent in vitro nucleosome reconstitution experiments hinted at a function
for H2Aub in chromatin compaction. Nucleosome arrays containing H2Aub exhibit a
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somewhat higher propensity than unmodified arrays to oligomerize at high concentrations
of divalent cations. However, H2Aub seemed to have no affect on intra-array compaction
at lower divalent cation concentrations (Jason et al., 2001). The relative significance of
these results is debatable because it is unclear which of these in vitro experimental
models best mimics chromatin compaction in vivo.
The identification of Ring1B (a RING domain E3) as the major E3 ligase for
H2AK119 in mammalian cells represented a major step forward (Wang et al., 2004).
Ring1B knockout cells had been shown previously to have an embryonic lethal
phenotype, emphasizing the potential importance of H2Aub in embryonic development
(Voncken et al., 2003). Further, Ring1B is a member of PRC1 type PcG complexes and
was shown to be necessary for repression of key developmental regulator genes, such as
Hox genes (Cao et al., 2005; de Napoles et al., 2004; Wang et al., 2004; Wei et al., 2006).
In support of H2Aub involvement in transcriptional repression, the ubiquitin hydrolase
Ubp-M was shown to regulate transcriptional activation of Hox genes through
deubiquitylation of H2Aub (Joo et al., 2007) and depletion of Ubp-M from Xenopus
embryos resulted in homeotic phenotypes reminiscent of PcG mutants (Joo et al., 2007).
Taken together these results established a firm link between H2Aub and developmentally
regulated transcriptional repression.
Particularly relevant to this thesis, H2Aub was recently shown to participate in
direct enzymatic crosstalk with an MTase involved in transcriptional activation.
Nakagawa and colleagues tested whether H2Aub might inhibit transcription by directly
inhibiting methylation of H3K4 by the MTase complex, MLL3 (Nakagawa et al., 2008).
Indeed, nucleosomes reconstituted with endogenous H2Aub, but not endogenous H2A,
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inhibited the MLL3 MTase activity while deubiquitylation allowed for efficient di- and
trimethylation of H3K4, a marker of active transcription in vivo. Further, deubiquitylation
stimulated in vitro transcription at the transcriptional initiation step (Nakagawa et al.,
2008), which is generally in agreement with in vivo studies implicating H2Aub-mediated
transcriptional repression specifically at the elongation step through RNA Pol II stalling
(Stock et al., 2007) and inhibition of FACT-mediated chromatin remodeling of
transcribed regions (Zhou et al., 2008).
However, genome-wide analysis of PcG-dependent H2Aub found minimal
correlation between the level of H2Aub and transcription (Kallin et al., 2009), in contrast
to genome wide studies of H2Bub (Minsky et al., 2008). Unlike PcG-dependent
H3K27me3, the PcG-dependent H2Aub level at a promoters and transcription start sites
is not a good predictor of transcription level.
A recent paper published by Müller and colleagues may offer some explanation
and insights. Through a genetic screen for morphological PcG mutants in Drosophila,
they identified a novel ubiquitin hydrolase for H2Aub, Calypso. Intriguingly, this H2Aub
hydrolase biochemically purified with known PRC1 proteins and its hydrolase activity is
required for transcriptional repression of PcG target genes in vivo (Scheuermann et al.,
2010).

This data argues against a simple model of H2Aub directly inhibiting

transcription. Instead it suggests that for optimal gene repression, H2A may need to
undergo cycles of ubiquitylation and deubiquitylation similar to those demonstrated for
H2B in active transcription (Daniel et al., 2004; Henry et al., 2003; Wyce et al., 2007).
Also in 2010, Di Croce and colleagues identified an H2Aub binding protein,
ZRF1, which displaces PRC1 from PcG-repressed genes in a developmentally regulated
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fashion and de-represses their transcription (Richly et al., 2010). Rather than promote
H2Aub involvement in transcriptional activation, the authors argue that H2Aub marks
transcriptionally poised promoters (Richly et al., 2010)
Ubiquityation of H2A is also strongly implicated in the DNA damage response
(DDR) in mammalian cells. Unlike transcription, where H2Aub and H2Bub are
understood to broadly function antagonistically, in DDR, H2Aub and H2Bub function
synergistically to promote DNA repair (Bekker-Jensen and Mailand, 2011).

1.2.4

“Designer” nucleosomes to study enzymatic crosstalk
The previous sections of this introductory chapter reviewed what is known about

the biological function of four important histone PTMs: methylation of H3K27 and
H3K79, and monoubiquitylation of H2BK120 and H2AK119. However, the astounding
complexity in chromatin in vivo dictates that histone PTMs probably never function truly
in isolation. Recent genome-wide profiling studies of histone PTMs are starting to reveal
combinations of PTMs strongly associated in vivo with genome architecture and different
chromatin states, including transcriptional status (Kharchenko et al., 2011; Roudier et al.,
2011; Wang et al., 2008).
My major interest in this thesis work was to understand how combinations of
histone PTMs are established. One important mechanism is crosstalk between preexisting modifications on nucleosomes and the activity of other enzymatic activity on the
same nucleosome. Carefully designed in vitro studies are important for furthering our
understanding of crosstalk relationships. However, the inherent heterogeneity of histones
and nucleosomes purified from endogenous sources has often obstructed efforts to
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establish direct enzymatic crosstalk between PTMs. Histones expressed recombinantly in
E. coli, devoid of PTMs, can be reconstituted into nucleosomes (Luger et al., 1999), but
ideal substrates for enzymatic crosstalk studies require robust and specific installation of
site-specific modifications on histones, and this has proved challenging. Fortunately,
several groups have recently made large strides in developing chemical strategies for this
purpose (Allis and Muir, 2011; Chatterjee et al., 2010; McGinty et al., 2008; McGinty et
al., 2009b; Shogren-Knaak and Peterson, 2004; Simon et al., 2007; van Kasteren et al.,
2007). For the purposes of this thesis I utilized several of these approaches to generate
sufficient quantities of chemically defined H2AK119ub and H2BK120ub (Chatterjee et
al., 2010; McGinty et al., 2008; McGinty et al., 2009b) (Chapter 2). These designer
histones were incorporated into designer mononucleosomes for crosstalk studies with
histone methyltransferases (Chapters 3-5).
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CHAPTER 2: PREPARATION OF “DESIGNER” AND ENDOGENOUS NUCLEOSOMES
It is clear that post-translational modification of histone proteins plays a powerful
role in regulating DNA templated processes such as transcriptional activation and
repression, DNA replication, recombination, DNA damage repair, etc. However, in
endogenous chromatin, dozens of PTMs exist on histone proteins, with multiple
modifications on the same nucleosome, and found in myriad combinations. This
complexity makes it challenging to isolate the function of a particular modification.
Chemically defined histones and DNA sequences, when assembled into nucleosomes, can
be a powerful tool to study the function of histone modifications without complications
arising from the inherent heterogeneity of chromatin purified from endogenous sources.
For this thesis, a set of nucleosomes was generated to study direct enzymatic crosstalk
between histone ubiquitylation and histone methyltransferases, as described in
subsequent chapters.
Two complimentary methods were used to quantitatively install monoubiquitin at
position 119 in H2A and position 120 in H2B: semi-synthetic expressed protein ligation
(nearly native) and disulfide-mediated (ssUb) (Figure 2.1). Installation by these methods
is more specific for a particular lysine than in vitro enzymatic ubiquitylation, and they
generate histone-ubiquitin linkages that differ minimally from the native isopeptide
linkage (Chatterjee et al., 2010; McGinty et al., 2009b). The generation of these designer
ubiquitylated histones and their incorporation into mononucleosomes is described below.
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Figure 2.1
Site-specific monoubiquitylation to generate “nearly native” and
“ssUb” H2Bub, H2Aub. The four site-specifically ubiquitylated histones described in
this chapter are represented in cartoon form. Amino acid sequences of H2B and H2A
C-termini are shown below a wavy line representing the peptide backbone. A) “nearly
native” refers ubiquitylated histones generated by semi-synthetic expressed protein
ligation. This strategy results in an isopeptide linkage identical to native Xenopus laevis
H2BK120ub and H2AK119ub except for substitution of alanine for glycine as the final
amino acid of ubiquitin (G76A). B)“ssUb” refers to ubiquitylated Homo sapiens histones
generated through disulfide-mediated ubiquitylation at position 119 in H2A and position
120 in H2B.
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In addition, native nucleosomes from endogenous sources were isolated and
purified. Unlike designer nucleosomes, nucleosomes from endogenous sources carry a
complex mixture of posttranslational modifications, DNA sequence, and nucleosome
array lengths. Their ease of isolation allowed for preliminary studies of enzymatic
activity before moving on to the more precious designer nucleosome substrates.

2.1

Expressed protein ligation to generate “nearly native” H2Bub(G76A)
Expressed protein ligation (EPL) is a semi-synthetic technique that allows the

generation of a peptide bond between two polypeptides, one of recombinant origin and
one of synthetic origin (Muir et al., 1998). The use of a polypeptide of synthetic origin
allows the site-specific incorporation of a variety of biophysical probes, unnatural amino
acids, and post-translational modifications (Flavell and Muir, 2009). More specifically,
EPL is a ligation between a polypeptide with a C-terminal thioester and one with Nterminal cysteine. Ligations proceed through a reversible trans-thioesterification of the
C-terminal thioester by the N-terminal cysteine thiol, followed by an irreversible S- to Nacyl shift, resulting in peptide bond between the two polypeptides (Figure 2.2A).
Synthetic peptides with a N-terminal cysteine thiol can be prepared by solid phase
peptide synthesis (SPPS), and recombinant proteins with a C-terminal thioester can be
generated by thiolysis of an intein fusion protein. With the addition of thiols, a modified
intein spontaneously cleaves itself out of a fusion protein, leaving a C-terminal thioester
on the recombinant protein of interest (Figure 2.2B).
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A

B

Figure 2.2
Expressed protein ligation. A) basics of expressed protein ligation
between a polypeptide with a C-terminal thioester and a polypeptide with an N-terminal
cysteine, resulting in a peptide bond between them. Adapted from (Chatterjee and Muir,
2010). B) generation of a polypeptide with a C-terminal thioester by intein-mediated
thiolysis for use in expressed protein ligation. Adapted from (Flavell and Muir, 2009).

Dr. Robert McGinty, while a MD-PhD student in the lab of Dr. Tom W. Muir at
The Rockefeller University, harnessed EPL to produce H2B homogenously
monoubiquitylated at K120, the major H2B ubiquitylation site in chromatin. In this
synthesis he ligated two recombinantly expressed proteins to the same synthetic peptide
to generate the desired branched protein with the native isopeptide bond between them
(Figure 2.3).
Xenopus laevis H2B(1-116) and Ubiquitin(1-75) were expressed as fusion
proteins with the Mycobacterium xenopi GyrA intein and a C-terminal CBD (chitin
binding domain). Soluble fusion protein was purified from E. coli lysate with chitin resin.
Intein-mediated cleavage with the thiol 2-mercaptoethanesulfonic acid (MESNa) resulted
in H2B(1-116)-α-MES and Ub(1-75)-α-MES thioesters. The H2B(117-125) C-terminal
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peptide required two cysteines, one for each ligation reaction. For this purpose, a cysteine
was installed via an isopeptide bond to the ε-NH2 of H2BK120, which in addition to
providing the nucleophilic thiol for an EPL reaction also provided a linker to replace
glycine76 of ubiquitin in the final protein. Additionally, the first amino acid in the
synthetic peptide, representing alanine117, was changed to cysteine and reversibly
protected as a thiazolidine for the first ligation reaction, to limit ubiquitin ligation to the
desired internal site. Before the second ligation with H2B(1-116) thioester, thiazolidine
was converted to cysteine by treatment with methoxylamine at pH 5.

EPL 1

deprotection

EPL 2

desulfurization

Figure 2.3
Scheme for synthesis of xlH2Bub(G76A). As published by McGinty and
colleagues (McGinty et al., 2009), xlH2Bub(G76A) was generated by two sequential
expressed protein ligation reactions between H2BC synthetic peptide and the thioesters
8E  Ơ0(6 (3/  DQG +%  Ơ0(6 (3/  7KH SURGXFW RI WKH ILUVW
ligation was treated with methoxylamine at pH 5 to deprotect the N-terminal thiol on
+%&$IWHUWKHVHFRQGOLJDWLRQUHDFWLRQWKHF\VWHLQHVDWERWKOLJDWLRQMXQFWLRQVZHUH
GHVXOIXUL]HG WR DODQLQHV ILQDOO\ UHVXOWLQJ LQ WKH QDWLYH [O+% VHTXHQFH DQG WKH SRLQW
PXWDWLRQLQXELTXLWLQ *$ )LJXUHDGDSWHGIURP 0F*LQW\HWDO 
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EPL ligation reactions result in cysteines at each ligation junction. As these
cysteines are not in the endogenous sequence of H2Bub, desulfurization was performed
to convert the cysteines to alanines (He et al., 2003). Raney nickel (Yan and Dawson,
2001) or radical-initiated (Wan and Danishefsky, 2007) desulfurization was used to
convert H2B(A117C) to the native H2B(A117), resulting in a traceless ligation, and
Ub(G76C) was converted to Ub(G76A) (Figure 2.3).
It had been previously observed that H2Bub was required for detectable
methylation of H3K79 in vivo (Briggs et al., 2002; Ng et al., 2002b; Sun and Allis, 2002),
but the molecular basis of this crosstalk was unknown. Dr. McGinty incorporated his
EPL prepared H2Bub into nucleosomes and performed methyltransferase assays to show
that H2Bub can directly stimulate Dot1L MTase activity on H3K79, ruling out, at least in
vitro, the need for bridge/mediator proteins to generate the striking crosstalk between
these modifications (McGinty et al., 2008; McGinty et al., 2009b). Additionally, as these
experiments were performed with mononucleosomal substrates rather than with
nucleosomal arrays, they argued against H2Bub functioning merely as a wedge between
nucleosomes to expose nucleosomal axial surfaces for Dot1L binding and methylation of
H3K79. Whether ubiquitylation of H2BK120 allosterically regulates Dot1L or modifies
nucleosomal structure/dynamics remains an important open question.
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2.2

Application of expressed protein ligation to generate “nearly native”

H2Aub(G76A)1
Dr. McGinty’s elegant work with H2Bub and its stimulation of Dot1L illustrated
the power of using chemical-biology techniques to generate defined nucleosomal
substrates for in vitro enzymatic assays. Consequently, I was interested in using EPL to
site-specifically install ubiquitin on H2AK119, in order to study the function of this
abundant but enigmatic modification.

2.2.1

Traceless EPL at alanine to generate hsH2Aub(G76A)
Analogous to H2Bub(G76A), nearly native H2Aub requires ligation of Ub(1-75)

and H2A_ΔC-term thioesters to a synthetic peptide containing the H2A C-terminus
(H2AC). Standard EPL utilizes the amino acid cysteine at ligation junctions, which can be
subsequently desulfurized to alanine. In order to generate a traceless ligation between
ubiquitylated H2AC and H2A_ΔC, the ligation site should be placed immediately before
an alanine. There are two alanines in the C-terminus of Homo sapiens H2A, at positions
103 and 113 (Figure 2.4A), and ligation at either of these sites would be compatible with
H2AC synthetic peptide synthesis. However, the identity of the final amino acid in the
thioester must also be considered when choosing a ligation site. Proline, valine or
isoleucine in that position are particularly detrimental to ligation efficiency and/or
thiolysis yield (Blaschke et al., 2000). Isoleucine is present at position 102 in human
H2A, ruling this out as a suitable ligation site for EPL (Figure 2.4A). Therefore, position
Q112/A113 was chosen as the H2A ligation site. Using this ligation site, the three
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
1	
  Performed in close collaboration with Dr. Robert McGinty and Dr. Beat Fierz, then
members of the Laboratory of Synthetic Protein Chemistry at the Rockefeller University	
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components to produce nearly native hsH2Aub(G76A) by EPL are H2A(1-112)-α-COSR
and Ub(1-75)-α-COSR thioesters from intein mediated thiolysis and H2A(113-129)
synthetic peptide (Figure 2.4B,C).
The necessary synthetic peptide was synthesized by Dr. McGinty, and contributed
as part of our collaboration (Figure 2.4B). Two modifications were made to the H2A Cterminal sequence, one at each ligation site. For ligation to H2A(1-112)-α-COSR, the
first amino acid in the peptide, representing A113, was changed to cysteine and
reversibly protected as a thiazolidine. For ligation to Ub(1-75)-α-COSR, cysteine was
installed via an isopeptide bond to the ε-NH2 of the lysine representing K119. This
isopeptide linked cysteine serves as a nucleophilic thiol for the EPL reaction and also
provides the linker to replace glycine76 of ubiquitin in the final protein (Figure 2.4C).
The Ub(1-75)-α-MES thioester was generated by thiolysis with MESNa of an
Ubiquitin-GyrA-CBD fusion protein, as described above. The Ub-thioester ligated
efficiently to the H2AC peptide, generating Ub-H2Ac ligation product. Deprotection of the
N-terminal cysteine of Ub-H2Ac for next ligation with H2A(1-112)-α-COSR was also
accomplished efficiently.
However, recombinant expression of the hsH2A(1-112)-GyrA fusion protein
presented unanticipated challenges. Full-length histones are typically expressed at high
levels in E. coli and can be purified from inclusion bodies in denaturing conditions.
However, hsH2A(1-112)-GyrA fusion protein was expressed at extremely low levels in
both soluble and insoluble fractions. Inclusion of an N-terminal FLAG-tag increased
expression somewhat, but expression yields were still quite low. A variety of E. coli
expression strains, growth temperatures, and Isopropyl β-D-1-thiogalactopyranoside
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(IPTG) concentrations were tried in an effort to increase expression of the fusion protein.
The small about of protein that was expressed was affinity purified using either chitinagarose or Ni-NTA-agarose resin, for CBD and 6xHis tagged fusion proteins
respectively.
Poor expression was compounded by inefficient H2A(1-112) thioester generation.
Intein mediated thiolysis requires the intein domain to be properly folded, necessitating
cleavage of solubly expressed protein or refolded protein purified denatured from
inclusion bodies (Flavell et al., 2008). Whether using solubly expressed fusion protein or
refolded protein purified denatured from inclusion bodies, thiolysis was quite inefficient.
Thiolysis efficiency was not significantly aided by cleavage in solution as opposed to oncolumn.
After massive scale up of protein expression and thioester generation processes, a
small amount of purified H2A(1-112)-α-MES thioester was available for the final EPL
reaction with Ub-H2Ac. However, this ligation was significantly less efficient than the
first EPL between Ubiquitin and H2Ac peptide and we were never able to achieve
reliable mass spectrometry confirmation of HPLC purified products. Further, we were not
able to confirm the ubiquitylation site by western blot with an antibody specific for
H2AK119ub (Figure 2.4D), perhaps because the antibody is sensitive to having a
cysteine rather than glycine as the final amino acid in ubiquitin, right at the isopeptide
junction between the two proteins. Due to lack of other suitable ligation sites in the H2A
C-terminal tail, I abandoned an EPL approach to generate hsH2Aub(G76A) and instead
invested in a “disulfide-mediated” approach (Ch 2.3) to generate chemically-defined
H2Aub

for

enzymatic

crosstalk

studies
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with

histone

metyltransferases.

Figure 2.4

Scheme for synthesis of hsH2Aub(G76A). A) Homo sapiens H2Aub

showing ubiquitylation at the native site, K119, and the sequence surrounding this Cterminal tail modification. B) H2A(1-112)-GyrA-CBD/6xHis construct designed for
expression in E. coli, affinity purification, and intein-mediated thiolysis to generate
H2A(1-112)-α-MES. The H2Ac peptide synthesized by Dr. Robert McGinty is shown
below. C) Modeled after the synthesis of xlH2Bub(G76A), the synthetic scheme to
generate hsH2Aub(G76A) called for two sequential expressed protein ligation steps
between H2AC synthetic peptide and the thioesters Ub(1-75)-α-MES and H2A(1-112)-αMES. The product of the first ligation was treated with methoxylamine at pH 5 to
deprotect the N-terminal thiol on H2AC. After the second ligation, cysteines at both
ligation junctions were desulfurized to alanines, finally resulting in the native hsH2A
sequence and the point mutation in ubiquitin (G76A). D) as discussed in the text, final
yields of hsH2Bub(G76A) was extremely low and mass spectrometry was not able to
confirm the identity of the final product. Western blot analysis shown here confirms that
the hsH2Bub(G76A) generated is recognized by anti-H2A antibody, but the
ubiquitylation site, K119, could not be confirmed using a site-specific antibody, antiH2AK119ub. This result may be a false negative as it cannot be ruled out that the
antibody is sensitive to the identity of the final amino acid in ubiquitin at the branch point
between the polypeptides H2A and Ub.
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TESHHKAKGK -COOH

2.2.2

Traceless EPL at valine to generate xlH2Aub(G76A)
Dr. Beat Fierz, then a post-doctoral fellow in the lab of Dr. Tom Muir at the

Rockefeller University, continued to explore other methods to generate “nearly-native”
H2Aub. His efforts targeted ubiquitylation of the Xenopus laevis H2A sequence rather
than the human sequence due to improved expression characteristics of the xlH2A_ΔCterminal polypeptide. Perhaps more critically, he pursued modified chemistries that made
other ligation sites available in the H2A C-terminal sequence. Standard EPL utilizes a Nterminal cysteine for ligation with a C-terminal thioester (Figure 2.2). As recently
described (Haase et al., 2008), substitution of β,β-dimethylcysteine for cysteine allows
for effective ligation and can be desulfurized to the amino acid valine. A valine exists at
position 114 in H2A, and this ligation site proved to be dramatically more amenable to
traceless EPL generation of nearly native H2Aub. Dr. Beat Fierz graciously provided me
with sufficient sample for the crosstalk studies presented in Chapter 4.

2.3

Disulfide-directed ubiquitylation of H2B and H2A2
Concurrent with my attempts to generate nearly native hsH2Aub(G76A), Dr.

Champak Chatterjee, then a post-doctoral fellow in the lab of Dr. Tom Muir at The
Rockefeller University, was developing a disulfide-directed strategy to specifically install
monoubiquitin on histone proteins. The highly nucleophilic sulfhydryl side chain of
cysteine presents a convenient site to add functional groups to mimic natural posttranslational modifications of proteins, and such an approach had previously been used
by several groups to site-selectively install sulfur-containing analogs of lysine
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
2
Performed in close collaboration with Dr. Champak Chatterjee, then a member of the
Laboratory of Synthetic Protein Chemistry at the Rockefeller University
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methylation (Simon et al., 2007) and glycosylation (van Kasteren et al., 2007). Dr.
Chatterjee recognized that histones and ubiquitin are perfectly suited for disulfidedirected strategies because these proteins lack cysteines in their native sequence (except
for C110 of histone H3, which can be mutated to alanine without appreciably affecting
nucleosome structure (Simon et al., 2007)). This characteristic allows for great specificity
in installation with minimal additional effort to reversibly protect other sulfhydryls.
Dr. Chatterjee developed an efficient and rapid method to generate Xenopus laevis
H2BssUb as an analog to nearly native H2Bub(G76A) for structure/function studies of
Dot1L stimulation by monoubiquitylated histones (Chatterjee et al., 2010). The resulting
disulfide linkage between ubiquitin and H2B is one atom longer (~ 2.4 Å) than the native
isopeptide bond (Figure 2.5E), but importantly, H2BssUb mimicked nearly native H2Bub
in Dot1 stimulation assays (Chatterjee et al., 2010). Unable to generate sufficient
quantities of sufficient quality of nearly native H2Aub(G76A) by EPL (Chapter 2.2), this
disulfide-directed strategy provided me with an alternative method to generate
chemically-defined ubiquitylated H2A.
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Figure 2.5

Scheme for synthesis of H2AssUb and H2BssUb by disulfide-mediated

ubiquitylation. As published by Chatterjee and colleagues (Chatterjee et al., 2010), sitespecificity of disulfide-mediated monoubiquitylation is achieved by genetic substitution
of the thiol containing cysteine at the desired ubiquitylation site. A) Full-length Homo
sapiens H2AK119C and H2BK120C were expressed in E. coli and purified, cysteine
sulfhydryl circled in blue. B) Intein-mediated thiolysis of full-length ubiquitin and
concomitant addition of aminoethanethiol to the C-terminus. C) The C-terminal thiol of
ubiquitin-aminoethanethiol

was

protected

by

treatment

with

2,2’-dithiobis(5-

nitropyridine) (DTNP) in acetic acid. D) Formation of the desired asymmetric disulfide
bond between H2AK119C or H2BK120C and Ub-aminoethanethiol. E) The disulfide
bridge between histone-cysteine and ubiquitin-aminoethanethiol results in a linkage ~ 2.4
Å longer than the native isopeptide bond. Figure adapted from (Chatterjee et al., 2010).
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In order to generate H2AssUb and H2BssUb (Figure 2.1B), the lysines at position
119 and 120, in human H2A and H2B sequences respectively, were genetically modified
to cysteine (Figure 2.5A). Full-length histones carrying the K to C mutation were
expressed in E. coli and purified from inclusion bodies. During histone purification and
affinity tag cleavage, β-ME was used as a reducing agent because of its compatibility
with Ni-NTA resin. However, this results in the formation of β-ME-H2AK119C and βME-H2BK120C disulfide adducts, leaving the histone sulfhydryls unavailable for
disulfide formation with ubiquitin. The undesired β-ME adducts were reduced with
20mM Tris(2-carboxyethyl)phosphine) (TCEP) and reducing agents removed by HPLC
purification before H2AK119C and H2BK120C could be used in ligation reactions with
ubiquitin.
Full-length ubiquitin was expressed as a fusion protein with GyrA intein and CBD
and then purified on chitin resin. The desired sulfhydryl group and two-carbon linker
were introduced onto the C-terminus of ubiquitin by intein-mediated thiolysis with
cystamine-dihydrochloride followed by an intra-molecular S- to N-acyl shift (Figure
2.5B). The C-terminal thiol group was then activated/protected by reacting it with 2,2’dithiobis(5-nitropyridine) (DTNP) and HPLC purified (Figure 2.5C). Before proceeding
to disulfide formation with either H2AK119C or H2BK120C, Ub-aminoethane-pNpys
(Ub-pNpys) was HPLC purified away from any remaining unreacted cystamine in order
to prevent it from competing with Ub-pNpys in disulfide formation with H2AK119C and
H2BK120C (Figure 2.5D). Failure to remove unreacted cystamine before ligation
resulted in large reductions in the final yield of H2AssUb and H2BssUb.
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2.4

Designer octamer generation
With

xlH2Bub(G76A)

(Chapter

2.1),

xlH2Aub(G76A)

(Chapter

2.2.2),

hsHBAssUb and hsH2AssUb (Chapter 2.3) in hand, unmodified histones were prepared
for designer octamer generation. Briefly, N-terminal 6xHis tagged histones were
expressed in E. coli, extracted from inclusion bodies and purified with Ni-NTA affinity
resin. TEV or Precision proteases were employed to remove the 6xHis tag from
H3.2C110A, H4, H2A, and H2B. Note that because the integrity of the eventual disulfide
bond between H2AK119C, H2BK120C and Ub-aminoethanethiol is extremely sensitive
to reducing agents, any residual reducing agents from all histone preps (not only
H2AK119C and H2BK120C, as described above) were removed by extensive dialysis
and/or HPLC purification.
Unmodified and ubiquitylated histones were assembled into designer octamers of
7 types: Xenopus unmodified, H2Bub(G76A) H2Aub(G76A); human unmodified,
H2AssUb, H2BssUb, and H2AssUb/H2BssUb. Briefly, denatured histones were
combined in dialysis buttons such that H3 and H4 were slightly limiting and dialyzed into
high salt buffer. Octamers were purified from unincorporated dimers, individual histones
and aggregates by Superdex 200 size exclusion FPLC (Figure 2.6). Pooled fractions
corresponding to octamers (biased towards the front of the peak because H3/H4 tetramers
do not separate well from octamers by Superdex 200 size exclusion chromatography)
were verified by SDS-PAGE (Figure 2.7, 2.8A).
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Figure 2.6

Assembly and purification of designer octamers. Unmodified and

ubiquitylated histones were appropriately combined in denaturing buffer and dialyzed
into high salt buffer to assemble 7 designer octamers: Xenopus unmodified,
H2Bub(G76A) and H2Aub(G76A); human unmodified, H2AssUb, H2BssUb, and
H2AssUb/H2BssUb. Octamers were purified by size exclusion chromatography using
Superdex 200 columns from GE Healthcare, a PC 3.2/30 column for assemblies < 1 mg,
or a 10/300 GL column for larger-scale assemblies. Representative chromatograms are
shown, A280 absorbance graphed as a function of time. Octamer peak fractions were
pooled as indicated (red box).
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Figure 2.6
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Characterization of “nearly native” ubiquitylated Xenopus octamers.

The purity and expected 1:1:1:1 ratio of histones H3, H4, H2A/H2Aub, and H2B/H2Bub
of Xenopus octamers was assessed by Coomassie staining of SDS-PAGE gels.

For ssUb octamers, the specificity of ubiquitin attachment and its reversibility
with reducing agents were confirmed by western blot analysis with antibodies specific for
H2AK119ub and for H2BK120ub (Figure 2.8C). For reasons that are not clear, the
disulfide bridge between ubiquitin and H2AK119C or H2BK120C is nearly completely
reduced if run on a standard SDS-PAGE Tris-Glycine precast gel made by Invitrogen but
not on a seemingly equivalent precast gel made by Bio-Rad, or on standard “hand
poured” SDS-PAGE Tris-Glycine gels (Figure 2.8B).
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Figure 2.8

Characterization of “ssUb” human octamers. Octamers assembled

from human unmodified and ssUb histones were electrophoresed on SDS-PAGE gels. A
B) octamer quality was assessed by Coomassie staining. C) SDS-PAGE separated
octamer samples -/+ beta-mercaptoethanol (β-ME) were transferred to PVDF membrane,
stained with Direct Blue, and subjected to western blotting with the indicated antibodies.
Nuclei from mouse embryonic stem cells (ESC) were used to mark the migration position
of endogenous H2AK119ub and H2BK120ub.
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2.5

Designer mononucleosome generation
Relative to other histone PTMs, monoubiquitylation is an extremely bulky

modification (itself being ~ 60% of the molecular weight of histones H2A and H2B). For
enzymatic crosstalk studies I wanted to eliminate the possibility that ubiquitylation
dependent changes in array conformation could alter the accessibility of a target lysine
for subsequent methylation. Therefore, I assembled octamers into mononucleosomes
using a 153bp sequence containing the 601 strong positioning sequence (Lowary and
Widom, 1998). DNA fragments for mononucleosome assemblies were prepared by
EcoRV digest of 32x153bp tandem repeats cloned into pUC19 (a kind gift from Dr. Kyle
Chiang, Tom Muir Laboratory) (Figure 2.9A). After extensive digest, plasmid backbone
fragments were PEG precipitated, and soluble 153bp fragments were purified with
several phenol/chloroform extractions and ethanol precipitated (Figure 2.9B).
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Figure 2.9
Preparation of 601 positioning sequence DNA for mononucleosome
assemblies. A) 153bp DNA fragments containing the 147 bp 601 positioning sequence
were prepared by EcoRV restriction digest of 32x153bp tandem repeats of the 601
sequence cloned into pUC19. B) EtBr stained 1% agarose gel of the 153bp DNA purification procedure. Plasmid DNA was digested with EcoRV. 153bp DNA fragments were
purified by plasmid backbone precipitation in 500 mM NaCl and 7.5% polyethylene
glycol (PEG-6000).
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Mononucleosomes were assembled by gradient dialysis from high salt to low salt
over approximately 24 hours, as previously described (Ruthenburg et al., 2011). The
precise molar ratio of octamer to nucleosome positioning sequence is critical for
successful nucleosome assemblies. However, histone proteins are low in aromatic amino
acids (tryptophan, tyrosine, and phenylalanine), and so absorb 280nm light poorly,
making accurate assessments octamer concentrations difficult. Therefore, with each batch
of octamers, small scale assemblies were carried out, carefully titrating the octamer:DNA
ratio. Too little DNA results in poor nucleosome assembly yield, while too much DNA
results in soluble unincorporated DNA (Figure 2.10A). Most enzymes that act upon
chromatin substrates have DNA binding activity. Recognizing that unincorporated DNA
could influence the results of enzymatic activity assays, all assemblies were checked for
free DNA by native 5% polyacrylamide gel electrophoresis and ethidium bromide
staining (EtBr) (Figure 2.10).
Native gel electrophoresis was also used to assess the structural homogeneity of
mononucleosome assemblies. Typically mononucleosome assemblies resulted in one
shifted EtBr stained band. However, my initial assemblies with xlH2Bub(G76A) and
xlH2Aub(G76A) octamers resulted in two shifted bands (Figure 2.10B). This was a
puzzling result as 153bp DNA should not be long enough to allow for nucleosome
positional isomers, and attempts to heat reposition nucleosomes at 55 degrees had no
impact. If hexamers contaminated the octamer pool, they could result in multiple shifted
EtBr stained bands on a native gel. However, the position of the lower band appeared to
be too high to be the result of DNA associated with a hexamer (H3/H4 tetramer plus one
H2A/H2Bub dimer), and Coomassie staining of the octamer pools did not suggest that
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H3/H4 were present at greater than equimolar amounts (Figure 2.7).

Interestingly,

assemblies using extremely high ratios of nearly native ubiquitylated octamers to DNA
(1.9 H2Bub oct:1 DNA; 2.3 H2Aub oct:1 DNA) resulted in only one shifted band (Figure
2.10B,C), solving the assembly problem with these designer octamers. Interestingly,
H2AssUb, H2BssUb, and not even H2AssUb/H2BssUb nucleosomes assemblies ever
gave this doublet pattern, suggesting that ubiquitylated octamers are not inherently
refractory to efficient mononucleosome assembly. However, I was not able to determine
why nearly native ubiquitylated octamers behaved differently from ssUb octamers in
these assemblies.
Anticipating the disulfide linkage in the ssUb nucleosomes could present
challenges for biochemical studies given the frequent necessity of reducing conditions for
enzymatic activity, I performed a titration with dithiothreitol (DTT) to ascertain whether
there are low concentrations of reducing agent that would leave the histone-ubiquitin
disulfide bond appreciably intact (Figure 2.11). However, even at 5 µM DTT, the
mobility of H2AssUb and H2BssUb nucleosomes on native PAGE gels indicated partial
disulfide reduction. Additionally, H2AssUb mononucleosomes were found to be
approximately 3 times more sensitive to DTT than their H2BssUb counterparts. This is
reminiscent of the differential accessibility of H2AK1119ub and H2BK120ub to trypsin:
H2AK119ub in endogenous chromatin is trypsin sensitive while H2BK120ub is resistant
(Bohm et al., 1982; Bohm et al., 1980).
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Figure 2.10

Designer mononucleosomes. “Designer” octamers were assembled into

mononucleosomes with 153 bp (601) positioning sequence DNA. Mononucleosome
(MN) assembly quality was assessed by native 5% PAGE and EtBr staining. 1 kb plus
ladder (M) from NEB. Numbers above lanes are molar ratios of octamers : DNA used in
nucleosome assembly. A) titration of octamers (oct) to DNA. B) relatively high ratios of
nearly native ubiquitylated octamers are required for high quality mononucleosome
assemblies, see text. C-D) Representative nucleosome assemblies of high quality are
shown.
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Figure 2.11 Characterization of sensitivity of ssUb nucleosomes to reducing
agents. H2AssUb and H2BssUb mononucleosome assemblies were adjusted to the indicated dithiothreitol (DTT) concentrations and incubated at 37° C for 3 hours before separation on native 5% polyacrylamide gels. The gels were stained with EtBr to assess the
stability of the disulfide bond between histone and ubiquitin. Unmodified human nucleosomes were used as a marker for where de-ubiquitylated ssUb nucleosomes should
migrate.

2.6

Endogenous HeLa nucleosomes
To complement the designer ubiquitylated mononucleosomes described above,

endogenous nucleosomes were purified from HeLa cells. With only minor alterations to a
published protocol (Fang et al., 2004), pools of native nucleosomes of differing array
lengths were isolated (Figure 2.12). It seems likely that these different pools of
nucleosomes, with different MNase digestion properties, may represent biochemically
and perhaps physiologically different chromatin domains. Western blotting revealed that
acetylation and methylation PTMs were well preserved through the isolation and
purification procedure, however, the bulk of ubiquitylation on H2A and H2B was lost,
presumably due to residual ubiquitin isopeptidase activity in the chromatin extracts.
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Briefly, HeLa nuclei were prepared by detergent cell lysis and mild douncing.
Nuclei were subjected to relatively mild MNase digestion, and most non-histone proteins
were stripped off MNase solubilized chromatin with 750 mM NaCl. Solubilized
chromatin fragments of variable length were fractionated on a linear 5-30% sucrose
gradient with ultracentrifugation. Fractions near the top of the gradient contain
mononucleosomes and fractions near the bottom of the gradient contain long
oligonucleosome arrays, with intermediary length arrays concentrated in the middle
fractions (Figure 2.12A). In addition to fractionating based on chromatin fragment length,
these gradients also separated nucleosome-associated proteins from nucleosomal
histones. Fractions in lower part of the gradient contain virtually no detectable protein
besides core histones, but fractions near the top of the gradient contain significant
quantities of contaminating proteins (Figure 2.12B). “Relatively clean” oligonucleosome
fractions were pooled and split in half. One half was subjected to additional mild MNase
digestion (to generate mono, di and tri nucleosomes), and then both halves were purified
and fractionated again on 5-30% sucrose gradients. Finally, gradient fractions were
pooled according to array length (Figure 2.12C). Coomassie staining of these pools
revealed them to be nearly devoid of non-histone proteins (Figure 2.12D).
These endogenous nucleosome pools, with relatively native and complex PTM
profiles, provide substrates for enzymatic crosstalk experiments that are complimentary
to the chemically defined designer mononucleosomes described above. Further, their ease
of preparation allowed for many pilot experiments before using the more precious
designer mononucleosomes.
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Figure 2.12

Preparation of endogenous nucleosomes from HeLa cells. MNase

solubilized and salt extracted HeLa chromatin can be fractionated over linear sucrose
gradients to yield nucleosome fractions that can be pooled based on nucleosome array
length. A-B) after one round of MNase digest and sucrose gradient purification, fractions
containing oligonucleosomes and relatively free of non-histone proteins were pooled. CD) a portion of these pooled oligonucleosomes was digested further with MNase, before a
second round of purification and fractionation on sucrose gradients. Final nucleosome
fractions were pooled based on nucleosome array length (into a – f) and the absence of
detectable non-histone proteins was confirmed by SDS-PAGE electrophoresis and
Coomassie staining.
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Figure 2.12
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CHAPTER

3:

SPECIFICITY

OF

ENZYMATIC

CROSSTALK

BETWEEN

HISTONE

UBIQUITYLATION AND H3K79 METHYLATION

One of the key outstanding questions in chromatin biology is how histone PTMs
are coordinately regulated to generate meaningful combinations of “marks” at
physiologically appropriate genomic locations. One important mechanism is “crosstalk”
between pre-existing histone PTMs and enzymes that add or remove subsequent
modifications on chromatin. Dot1 methyltransferase for H3K79 is one such enzyme
whose activity is sensitive to the presence of pre-existing PTMs on its nucleosomal
substrate (Figure 3.1). The set of designer ubiquitylated and endogenous nucleosomes
prepared in Chapter 2 allowed me to do a series of in vitro enzymatic assays to
investigate the specificity and plasticity of crosstalk between H2BK120ub, H2AK119ub,
and H3K79me.

3.1

Dot1, evolutionarily conserved methyltransferase for H3K79
Dot1 is an evolutionarily conserved methyltransferase specific for K79 in histone

H3 (Feng et al., 2002; Lacoste et al., 2002; Ng et al., 2002a; van Leeuwen et al., 2002).
Dot1 family MTases are is critical for telomeric maintenance, DNA damage response,
and many developmental processes including embryogenesis (Jones et al., 2008),
hematopoeisis and leukemia (Feng et al., 2010), and cardiac development (Nguyen et al.,
2011). Therefore, understanding how Dot1 activity is regulated is an important question
to be addressed.
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Figure 3.1 Histone features that affect Dot1 methyltransferase activity in their nucleosomal
context. Surface rendition of mononucleosome structure, Protein Data Bank code 1KX5. A)
axial view, B) radial view. DNA is colored in black and the histones H3, H4, H2A, and H2B are
colored green, lavender, yellow, and orange respectively. The Dot1 methylation site, H3K79, is
colored in dark blue. Two patches of amino acid residues are circled in red, the “H4 N-tail basic
patch” and the stimulatory ubiquitin patch. H4 K16, R17 and R19 are colored in red because they
are critical for Dot1 activity towards H3K79. Similarly, within the “stimulatory ubiquitin patch”,
positions that when ubiquitylated strongly stimulate Dot1 activity are colored in red.
Ubiquitylation at H2BK116 only moderately stimulates Dot1 and is colored in pink. Outside of
the stimulatory patch, H2BK108 is colored in grey because ubiquitylation at this position does
not stimulate Dot1 activity. H2AK119, located at the opposite side of the nucleosome axial face
is colored in brown. H2BK34, located between DNA gyres, is colored in red as ubiquitylation at
this site greatly stimulates Dot1 methyltransferase activity.
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The yeast yDot1p and human hDot1L have been most extensively studied, and
they share a strongly conserved catalytic core, but outside of this relatively small region
of homology, their protein sequences differ significantly, as highlighted in Figure 3.2.
Most obviously, hDot1L is approximately 3 times larger in size than yDot1p. Secondly,
the position of the only other annotated region, the lysine rich region, relative to the
methyltransferase domain differs between yDot1p and hDot1L. These structural
differences in the polypeptides may contribute to differences in regulation of yDot1p and

Ly
s

ric

h

hDot1L’s shared catalytic activity.

yDot1p

MTase
231

582

Ly
s

ric

h

1

hDot1L

MTase
1

332

1739

Figure 3.2 Domain structure of yeast and human Dot1 methyltransferase. The domain
structure of yDot1p (Q04089) and hDot1L (Q8TEK3) are represented. Methyltransferase
domains, highly conserved between the yeast and the human proteins, are shown in orange
(MTase). Lysine rich regions, ~ 65 amino acids in length, are indicated in green. Amino acid
positions are indicated below.

The in vivo steady state levels of K79 unmodified, monomethyl (me1), dimethyl
(me2), and trimethyl (me3) differ greatly between yeast and human cells. Approximately
90% of yeast H3 is methylated at K79, the majority of which is in the trimethylated state
(Garcia et al., 2007; van Leeuwen et al., 2002). Whereas, in mouse and human cells only
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about 50% of H3K79 is methylated, with monomethyl being the predominant state and
trimethylation being undetectable by mass spectrometry (Garcia et al., 2007). Whether or
not these differences in steady state levels are due to intrinsic differences in Dot1
enzymatic activity, differential regulation in vivo, or to differential activity of yet to be
discovered demethylation machinery in vivo is not known at this time.

3.2

DNA binding is critical for Dot1 methyltransferase activity
As mentioned above, both yeast and human Dot1 proteins contain an

unstructured, highly basic patch, rich in lysines and arginines, either N-terminal to (in the
case of yDot1p) or C-terminal to (in the case of hDot1L) the methyltransferase domain.
There is little sequence conservation between these regions, but their importance for
DNA binding and catalytic activity is conserved. Specifically, this region is essential for
enzymatic activity (Feng et al., 2002; Min et al., 2003; Sawada et al., 2004). Even a 17
amino acid deletion (removing 9 of the 15 positive charges in this basic region) is
sufficient to very strongly repress catalytic activity (Min et al., 2003). Gel shift
experiments with Dot1 protein mutants and mononucleosomes, suggested that this same
basic region of Dot1 is necessary for DNA binding, thereby conferring intrinsic
nucleosome binding activity to the yeast Dot1p (Sawada et al., 2004). Further, Dot1 does
not methylate H3 unless in the context of chromatin or nucleosomes (Feng et al., 2002;
van Leeuwen et al., 2002). This data suggests that the lysine-rich region is necessary for
catalytic activity because of its role in substrate binding. However, the defect in catalytic
activity of yDot1p missing this lysine rich region can be nearly rescued by pre-incubation
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with short pieces of DNA (30-150 bp) (Sawada et al., 2004), suggesting that the role of
this lysine rich region and DNA binding is more complicated than simple recruitment.

3.3

Indirect in vivo crosstalk between H4K16Ac and H3K79methylation
In addition to intrinsic DNA binding activity, Dot1 methylation activity also

requires binding to a basic patch in the H4 N-terminal tail (y16-20) (Altaf et al., 2007),
located very close to H3K79 on the axial surface of the nucleosome (Luger et al., 1997)
(Figure 3.1). It is tempting to speculate that the function of this interaction is to correctly
position Dot1 for methylation of H3K79. Binding to this region of the H4 tail is
exquisitely sensitive to the charge state at position R17 and R19, but is unaffected by
acetylation (removal of positive charge) on K16. In contrast to the in vitro results, H4K16
acetylation in vivo facilitates H3K79me by disrupting the binding of heterochromatic
protein Sir3, which competes with Dot1 for binding to the nucleosome (Altaf et al.,
2007). Therefore, in vivo H4K16Ac participates in indirect crosstalk with
H3K79methylation.

3.4

Direct Enzymatic crosstalk between H2Bub and H3K79methylation
In landmark papers for trans-histone tail crosstalk, monoubiquitylation of

H2BK120 was shown to be an in vivo requisite for methylation of H3K79 (Briggs et al.,
2002; Ng et al., 2002b; Sun and Allis, 2002). Although crucial first steps, these yeast
genetic studies were not able to rule out indirect effects as the cause of the observed
striking ubiquitin-methylation crosstalk. However, subsequent work by McGinty and
colleagues using semi-synthetic H2Bub incorporated into designer nucleosomes and
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purified enzyme, showed that H2Bub directly stimulates Dot1L methylation of H3K79
(McGinty et al., 2008). Dot1L binding to nucleosomes was not shown to be sensitive to
the presence of H2Bub (McGinty et al., 2008; McGinty et al., 2009b), arguing against a
simple recruitment function for H2Bub in the stimulatory crosstalk.

3.5

Preparation of recombinant hDot1L methyltransferase
Interested in exploring mechanism of ubiquitin-mediated modulation of Dot1

activity, I took an in vitro approach using recombinant Dot1 and the designer
mononucleosomes described in Chapter 2. Aware of the potential differences in
regulation of yDot1p and hDot1L, I chose not to mix organisms and used recombinant
human Dot1L as well as nucleosomes of human origin, either assembled from
recombinant/designer human histones or purified from the human cell line, HeLa.
Full-length human Dot1L protein was over-expressed in insect cells and purified
(Figure 3.3). Briefly, soluble FLAG-hDot1L was affinity purified with M2 resin and
eluted with multiple rounds of incubation with excess 3xFLAG peptide. Elutions were
pooled. Although degradation products were detectable by Coomassie staining and M2
western blotting, the quality of the prep (in terms of integrity of full length Dot1L) was
comparable to those regularly obtained by members of the Muir laboratory. Purified
methyltransferase was sufficiently active to use at 1 mole enzyme : 30 moles
nucleosomal substrate in the following experiments.
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Figure 3.3 Purification of recombinant Flag-hDot1L. Flag-hDot1L was expressed and
purified from baculovirus infected Sf9 cells. A) Coomassie stained SDS-PAGE gel of samples
from the purification procedure. Flag-hDot1L was purified from soluble cell lysate with M2
anti-FLAG affinity resin and serially eluted with 3xFLAG peptide. B) Elutions 1-5 were pooled
and western blotted with M2 antibody to confirm the major band as Flag-hDot1L. Lanes are
labeled: soluble cell lysate (IN), M2 resin flow through (FT), washes 1, 5 (W), M2 resin after
elutions (R).

3.6

Ubiquitin stimulates Dot1L activity in cis
I asked whether free ubiquitin could affect HMTase activity in trans. Dot1L

binding of free ubiquitin could stimulate activity on unmodified nucleosomes (if
ubiquitin functions allosterically) or could inhibit activity by competing with
nucleosomes for binding of Dot1L. However, I found that neither 2 nor 20 molar
equivalents (to nucleosomal substrates) of free ubiquitin had any significant impact on
Dot1L HMTase activity on mononucleosomes purified from HeLa cells (Figure 3.4),
similar to the findings of others (McGinty et al., 2008). In further support of this result,
Chatterjee and colleagues used a modified ubiquitin moiety containing a variable length
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glycine linker to show that the native distance between the globular fold of ubiquitin and
the nucleosomal surface was optimal for Dot1L stimulation (Chatterjee et al., 2010).

CPM 3H incorporation
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Dot1L
no enzyme
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0

nucl
-

nucl
2x Ub

nucl
20x Ub

2x Ub

20x Ub

-

Figure 3.4 Ubiquitin does not stimulate Dot1L activity in trans. MTase reactions were
assembled with Flag-hDot1L, HeLa nucleosomes and soluble ubiquitin, as indicated.
Soluble ubiquitin was either absent from the reaction or added in 2x or 20x nucleosome
molar equivalents. Methyltransferase activity was quantitated by filter binding and
scintillation counting of incorporated 3H-CH3. Error bars represent the standard
deviation of replicate scintillation counts.

3.7

Histone ubiquitylation positional plasticity in Dot1L MTase stimulation
Interested in investigating the specificity/plasticity of monoubiquitylation

stimulated Dot1L activity, and guided by atomic level structural knowledge of the
nucleosome (Luger et al., 1997), Chatterjee et al. used lysine to cysteine mutagenesis of
histone sequences and disulfide-directed monoubiquitylation to move the ubiquitylation
site around on the axial surface of the nucleosome (Chatterjee et al., 2010). This panel of
monoubiquitylated nucleosome was used as substrates for Dot1L MTase assays to query
the spatial and sequence specificity of ubiquitin stimulation of Dot1L. Specifically,
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ubiquitin was attached at position G22 of H2A, and K116, 125, and 108 of H2B (in order
of increasing distance from the native H2BK120 site. Of these positional isomers, only
attachment at position 108 of H2B failed to stimulate HMTase activity. This analysis
revealed that Dot1L stimulation does not strictly depend on the sequence surrounding the
ubiquitylation site or the precise position of the attachment on the nucleosomal surface.
However, not all ubiquitylation sites were equally stimulatory. In fact, despite being
extremely close to the native attachment site, ubiquitylation at H2BK116 was only
moderately stimulatory. Notably, nucleosomes assembled with the weakest stimulators
(ubiquitylation at K108 and K116 of H2B) also migrated faster than the others in the
panel on native gel electrophoresis. This suggests that the precise ubiquitin attachment
site may influence the surface-charge or nucleosome structure, characteristics which may
also affect the ubiquitylated nucleosome’s ability to stimulate Dot1L HMTase activity.
Additionally, disulfide-directed and expressed protein ligation approaches were
used to incorporate structural relatives of ubiquitin, Smt3, Nedd8, and Hub1, at
H2BK120 and compared the ability of these modifications to mimic the stimulatory
effect of H2BK120ub on Dot1L activity. Neddylation at H2B position 120 could fully
substitute for ubiquitylation at the same position. However, Smt3 and Hub1were not able
to stimulate Dot1L activity (Chatterjee et al., 2010; McGinty et al., 2009b). These results
raised the possibility, that it is not merely the general size and fold of monoubiquitin that
stimulates Dot1, but that the crosstalk is sensitive to specific structural or sequence
elements on the surface of ubiquitin (and Nedd8) that are not mimicked in Hub1 or Smt3.
As valuable as these studies are to our understanding of Dot1L function, they
utilize nucleosome substrates that have not been observed in vivo. However, very
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recently, a novel H2B ubiquitylation site was discovered that also dramatically stimulates
Dot1L activity in vitro and in vivo (Wu et al., 2011). This site, H2BK34, has additional
interest because of its relatively great distance from H2BK120 and because rather than
being solvent exposed on the axial surface of the nucleosome, it is located between the
DNA gyres on the radial edge (Wu et al., 2011)(Figure 3.1). Taken together, these data
reveal significant positional plasticity in the histone ubiquitylation site for enzymatic
stimulation of Dot1.
The location of H2AK119ub, on the opposite end of the nucleosome axial face,
and its approximately 10 times greater abundance in vivo relative to H2BK120ub, make
H2Aub an interesting test case for the extent of Dot1L stimulation plasticity.
Additionally, H2Bub and H2Aub are known to have opposite effects on methylation of
H3K4 in vitro (Kim et al., 2009; Nakagawa et al., 2008), which begs the question
whether a similar antagonism exists in regulating H3K79methylation.

3.8

Dot1L activity is stimulated by Mg2+ and insensitive to DTT
Putative H2Aub inhibition of Dot1L activity would be difficult to detect in vitro

using published enzymatic assay conditions that have shown Dot1 activity on unmodified
nucleosomes to nearly undetectable (Chatterjee et al., 2010; McGinty et al., 2008). In the
course of this thesis work, various MTase reaction buffers were tried, and it was found
that Dot1L in vitro activity is extremely sensitive to the concentration of the divalent
cation, Mg2+ (Figure 3.5A). Even 1 mM Mg2+ is sufficient to increase Dot1 activity on
unmodified nucleosomes by approximately 10 fold over activity at 0 mM. In the presence
of Mg2+, Dot1L activity is high enough to allow detection of H2Aub inhibition, if present.
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Importantly, increased Mg2+ concentrations did not significantly change the strong
substrate preference of Dot1 for H2Bub nucleosomes as compared to unmodified
nucleosomes.
Before conducting crosstalk experiments between H2Aub and K79me, I first
confirmed that Dot1L methyltransferase activity is undiminished in non-reducing
conditions (Figure 3.5B). This characteristic of hDot1L activity allowed the use of ssUb
nucleosomes described in Chapter 2 to rigorously test for potential crosstalk between
H2Aub and H3K79methylation.

3.9

Use of ssUb nucleosomes to investigate potential crosstalk between H2Aub

and Dot1L
Dot1L methyltransferase activity on unmodified mononucleosomes was
compared to activity on 3 types of ubiquitylated nucleosomes: H2AssUb, H2BssUb, and
H2AssUb/H2BssUb (nucleosomes containing both H2AssUb and H2BssUb). As
previously reported (Chatterjee et al., 2010), H2BssUb greatly stimulates Dot1L activity
on nucleosomal H3. However, H2AssUb has little appreciable impact on Dot1L activity
relative to unmodified nucleosomes, and activity on H2AssUb/H2BssUb nucleosomes
was comparable to that on H2BssUb nucleosomes (Figure 3.6). The precise extent of
Dot1L stimulation by H2AssUb/H2BssUb nucleosomes varied between experiments
more than other substrate types, in some cases being slightly more stimulating to Dot1L
than H2BssUb alone, and in some cases being slightly less stimulating, as shown. Based
on these experiments I conclude that H2Aub does not influence Dot1L HMTase activity
in vitro.
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Figure 3.5 Dot1L activity is stimulated by Mg2+ and insensitive to reducing agent
concentration. A) Mg2+ titration of Dot1L methyltransferase activity on unmodified
mononucleosomes. B) DTT titration of Dot1L methyltransferase activity on HeLa
nucleosomes (blue) or without nucleosome substrates (green). Methyltransferase activity
was quantitated by filter binding and scintillation counting of incorporated 3H-CH3.
Error bars represent the standard deviation of replicate scintillation counts.
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Figure 3.6 Presence of H2Aub in mononucleosomes does not affect Dot1L MTase
activity. Dot1L activity was tested on human unmodified and “ssUb” mononucleosomes
as indicated. ¾ of each reaction was separated by SDS-PAGE and Coomassie stained (A)
and activity was assessed by fluorography (B). Activity was also assessed by filter
binding and scintillation counting of ¼ of each reaction (C). Error bars indicate the
standard deviation of replicate scintillation counts of the same filter paper. The asterisk
above the rightmost bar indicates an atypically high (~ 5x greater than normal)
scintillation count due to a technical artifact and is not from Dot1L self-methylation
activity. Note that the same sample produced no detectable fluorography signal (B).
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Although others have shown that Dot1L can be stimulated by ubiquitylation at a
variety of nucleosomal locations (Figure 3.1), under these assay conditions, plasticity of
stimulation does not extend to H2Aub. However, two lines of evidence may have
suggested that H2Aub would actually inhibit Dot1 activity: H2Aub and H2Bub have
roughly antagonistic roles in transcriptional regulation (Chapter 1), and they have been
shown to have opposite affects on the in vitro activity of methyltransferases for H3K4
(Kim et al., 2009; Nakagawa et al., 2008). Although H2Aub was found to neither activate
nor repress Dot1L activity in vitro, the results presented here provide further evidence of
differential function of H2Aub and H2Bub (Chapter 1).
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CHAPTER 4:

TESTING FOR CROSSTALK BETWEEN HISTONE UBIQUITYLATION AND

H3K27 METHYLATION
In Chapter 3, experiments to investigate modulation of Dot1L H3K79 MTase
activity by histone monoubiquitylation were presented. Previous studies had shown that
Dot1 activity is stimulated by histone monoubiquitylation at a variety of positions on the
nucleosome axial surface and even on the radial edge (Chatterjee et al., 2010; Wu et al.,
2011). However, this plasticity of ubiquitylation position does not extend to H2AK119,
as shown in Figure 3.6.
Here in Chapter 4, studies of potential crosstalk between histone ubiquitylation
and histone methyltransferases were extended to the methyltransferase Polycomb
Repressive Complex 2 (PRC2). Initially discovered as factors necessary for maintained
transcriptional repression of developmentally regulated genes (Kennison, 1995), PRC2 is
now known to be the multimeric protein complex responsible for H3K27 dimethylation
and trimethylation in vivo (Cao et al., 2002). Numerous studies have shown PRC2mediated transcriptional repression and H3K27 methylation to be involved in cellular
differentiation, stem cell identity, X inactivation, cell-cycle regulation, and cancer
(Margueron and Reinberg, 2011). Genes targeted by PRC2 have been mapped in a
variety of cellular contexts, and in many cases these genes can be either methylated on
H3K27, H3K4, or both, depending on the particular cellular/developmental context. In
fact, it has been proposed that the balance between H3K4me2/3 and H3K27me2/3 may
be an important mechanism of regulating transcription of many genes, particularly those
involved in cellular differentiation programs (Schuettengruber et al., 2007).
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Intriguingly, both H2Bub and H2Aub participate in direct enzymatic crosstalk
with methyltransferases for H3K4, however in antagonistic directions: H2Bub is required
for Set1-mediated methylation of H3K4 (Kim et al., 2009), while deubiquitylation of
H2Aub is required for MLL3-mediated methylation of H3K4 (Nakagawa et al., 2008).
Presented here in Chapter 4 are experiments to address whether the antagonistic crosstalk
between H2Aub and H2Bub on methylation of H3K4 is mirrored in antagonistic crosstalk
on PRC2-mediated methylation of H3K27 (Figure 4.1).

H2BK120ub
t1
Se

PRC2
Suz12-PRC2

?
Eed-PRC2

H3K4me3

H3K27me3
ML

L3

?
PRC2

H2AK119ub
Figure 4.1 Putative antagonistic crosstalk of H2Aub and H2Bub on H3K27 methylation.
Outlined are established and hypothesized crosstalk relationships between H2Bub, H2Aub,
H3K4me3, and H3K27me3. Validated direct enzymatic crosstalk between H2Bub/H3K4me3,
H2Aub/H3K4me3, H3K4me3/H3K27me3, and H3K27me3/H3K27me3 are shown with solid
arrows and with the relevant methyltransferase indicated above. Note that H2Bub and H2Aub
have opposing effects on H3K4 methylation in vitro. The regulation of transcription of a generic
gene is located in the center, showing the opposing action of H3K4me3 and H3K27me3 in
transcriptional regulation. Hypothesized crosstalk between H2Bub and H2Aub on
PRC2-mediated H3K27 methylation is indicated with grey arrows and question marks.
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4.1

Evolutionary conservation of Polycomb Repressive Complex 2
Genetic, biochemical, and bioinformatic approaches have identified and

characterized PRC2 components in organisms as divergent as plants, Drosophila, and
humans. Complexes purified from these diverse sources share H3K27-directed MTase
and transcriptional repression activity (Hennig and Derkacheva, 2009). Although fungi
might be expected to have PRC2 components given their common ancestor with plants
and animals, PcG proteins have yet to be identified in unicellular fungi, such as yeast.
However, Neurospora crassa, a filamentous fungus, has homologs of PRC2 components
(Schuettengruber et al., 2007). Given that PcG proteins are critical for cellular
differentiation, my colleagues and I speculated that genes for PRC2 components have
been retained in Neurospora because they contribute to the multicellular developmental
stages of this organism (Whitcomb et al., 2007).

4.2

Mammalian PRC2 core complex composition
PRC2 complexes have been isolated from a variety of cell culture systems

revealing some diversity in composition. However, regardless of the details of complex
purification, the core components present in mammalian PRC2 are Ezh2, Suz12, Eed, and
RbAp46/48 (Cao et al., 2002; Kuzmichev et al., 2002) (Figure 4.2A).
Ezh2 is the catalytic component of mammalian PRC2 and its MTase activity is
dependent upon the highly conserved SET domain (Chapter 1.2.2.1) (Cao et al., 2002;
Muller et al., 2002) (Figure 4.2B). Over the approximately 800 million years since the
divergence of our common ancestor, the human Ezh2 SET domain retained 86% amino
acid sequence identity and 93% similarity with the SET domain of its Drosophila
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homolog, E(z) (Whitcomb et al., 2007). Just N-terminal to the SET domain is another
highly conserved region, called the Pre-SET domain. This cysteine-rich region is required
for SET domain mediated methylation. Additionally, Ezh2 contains two SANT domains
that are predicted to bind histone tails (Boyer et al., 2004).
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Figure 4.2 Mammalian PRC2 core complex composition. A) subunits of core mammalian
PRC2 complex. Contacts shown do not necessarily represent those required for PRC2 complex
assembly. B-E) domain structures of the four core members of mammalian PRC2. Numbers
below each polypeptide indicate amino acid length. Methylation of H3K27 is mediated by the
catalytic SET domain in Ezh2 (orange). Other domains and motifs described in the text are
indicated: SANT (green), Pre-SET (dark orange), glycine-rich (yellow), C2H2 Zinc finger (pink),
VEFS-box (khaki), and WD-40 repeats (blue).
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Suz12 contains a classical C2H2 zinc finger domain similar to those found in
sequence specific DNA binding proteins which likely contributes to PRC2 binding to
nucleosomes (Birve et al., 2001; Nekrasov et al., 2005) (Figure 4.2C). At its N-terminus
is a short glycine-rich region and at its C-terminus Suz12 has a so-called VEFS-box,
named because this sequence is highly conserved between Suz12 and plant homologs
VRN2, EMF2, and FIS2 (Birve et al., 2001). The VEFS-box is required for Suz12
interaction with Ezh2 (Ketel et al., 2005; Yamamoto et al., 2004).
Eed is a WD-40 repeat protein that folds into a 7-bladed β-propeller (Han et al.,
2007) (Figure 4.2D). As is typical of WD-40 repeat proteins, the Eed β-propeller serves
as a large protein-protein interaction surface, important for complex assembly. It is on
one face of this propeller that Ezh2 binds. In the center of the Eed β-propeller donut-like
structure, but on the opposite face from the Ezh2 interaction surface, is an aromatic cage
capable of binding multiple histone peptides with methylated lysines. Although peptides
for H1K26me3, H3K9me3, H3K27me3, and H4K20me3 all bind with similar affinities in
the aromatic cage of Eed, methylated lysines associated with active transcription such as
H3K4me3 (Bernstein et al., 2005; Santos-Rosa et al., 2002), H3K36me3, and H3K79me3
do not bind (Margueron et al., 2009). It seems that evolution of the Eed protein has
selected for a β-propeller fold that selectively binds methylation states associated with
repressed transcription and excludes methylated lysines associated with active
transcription.
The final core member of mammalian PRC2 is RbAp46/48. Like Eed, it is a WD40 repeat protein that folds into a 7-bladed β-propeller (Murzina et al., 2008) (Figure
4.2E). Recently it was shown that the β-propeller of the Drosophila RpAp46/48
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homolog, Nurf55, binds unmodified H3 N-tail peptide but not the H3K4 trimethylated
peptide (Schmitges et al., 2011). Although Nurf55 interaction with the H3 N-tail is not
critical for PRC2 binding to nucleosomes (Schmitges et al., 2011), it appears to
allosterically influence Ezh2 activity, as will be discussed below.

4.3

In vitro PRC2 HMTase activity
Ezh2 is inactive as a methyltransferase in vitro unless associated with other PRC2

complex members (Czermin et al., 2002; Muller et al., 2002). Eed and Suz12 are
especially crucial for Ezh2 activity, both in vitro and in vivo (Cao and Zhang, 2004;
Montgomery et al., 2005; Pasini et al., 2004), and the addition of RbAp48 to Ezh2-EedSuz12 further stimulates MTase activity (Cao and Zhang, 2004).
It was recently shown that when added in trans, H3K27me3 peptide, but not other
methylated histone peptides, stimulates H3K27 methylation by PRC2 on nucleosomes
(Margueron et al., 2009; Xu et al., 2010). This end-product (H3K27me3) stimulation of
the enzyme (PRC2) was dependent upon amino acids in the Eed aromatic binding pocket
for methylated lysines (see above). Given that H3K27me3 was provided as a peptide in
trans, the stimulation is unlikely to be due to increased recruitment of PRC2 complex to
nucleosomal substrates. The authors proposed an allosteric effect on Ezh2 MTase activity
mediated by Eed-trimethylated lysine binding. If the role of H3K27me3 peptide in these
experiments can be played by nucleosomal H3 tails carrying methylated K27, then
perhaps these results point to a mechanism of H3K27methylation spreading in vivo.
Intriguingly, H3K4 methylation also can allosterically modulate PRC2
methyltransferase activity, although in the opposite direction of H3K27me3 (Schmitges
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et al., 2011) (Figure 4.1). Pre-methylation of H3K4 inhibits subsequent methylation of
K27 in the same H3 N-terminal tail (Schmitges et al., 2011). This presents an appealing
model for how Eed-mediated H3K27methylation spreading is restricted from
transcriptionally active genes.

4.4

Recombinant PRC2 complex preparation
Interested in exploring further how pre-existing histone PTMs, notably

monoubiquitylation on H2A and H2B, might modulate PRC2 methyltransferase activity
(Figure 4.1), I obtained recombinant PRC2 complex purified by Dr. Susan Wu, then a
PhD student in the laboratory of Yi Zhang at the University of North Carolina. Briefly,
Ezh2, FLAG-Eed, Suz12, and RbAp48 were co-expressed in Sf9 cells using a standard
baculovirus expression system, purified using M2 anti-FLAG affinity resin, and eluted
with 3xFLAG peptide. Eluates were pooled and PRC2 complex was purified away from
incomplete complex and other contaminating proteins by size exclusion chromatography
(Figure 4.3A).
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Figure 4.3 PRC2 activity is sensitive to the concentration
of cations and reducing agents. A) Coomassie stained
SDS-PAGE gel of reconstituted human PRC2 complex,
courtesy of Dr. Wu. (*) denote contaminating proteins or
proteolytic products. B-D) characterization of PRC2
methyltransferase sensitivity to the concentration of Mg2+,
Li+, and reducing agents, as quantitated by scintillation
counting of incorporated 3H-CH3. Error bars represent the
standard deviation of replicate scintillation counts. D) DTT
titration of PRC2 methyltransferase activity on unmodified
mononucleosomes (blue) or in the absence of nucleosomal
substrates (green).
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0mM Li+
no nucl

4.5

PRC2 activity is sensitive to the concentration of Mg2+, Li+, and reducing

agents
Before beginning crosstalk studies I performed several experiments to
characterize PRC2 activity on unmodified nucleosomes. Having observed that Dot1L
MTase activity is strongly stimulated by Mg2+ (Figure 3.5A), I tested recombinant PRC2
complex for the same sensitivity. PRC2 activity was also found to be sensitive to the
concentration of Mg2+, although not as drastically as Dot1L (Figure 4.3B). PRC2 activity
on unmodified mononucleosomes was approximately 6x higher at 2 mM Mg2+ than in the
absence of Mg2+. This increased activity was practically useful because it allowed the use
of far less PRC2 complex per enzymatic activity assay. Contrary to the stimulatory effect
Mg2+, the monovalent cation Li+ has a strong inhibitory effect on PRC2 methyltransferase
activity (Figure 4.3C). 16 mM Li+ is sufficient to depress PRC2 activity on unmodified
mononucleosomes to background levels.
Thinking forward to potential crosstalk experiments using the designer ssUb
nucleosome set described in Chapter 2, the sensitivity of PRC2 activity to the
concentration of reducing agents needed to be critically assessed. Unlike Dot1L activity
that showed essentially no sensitivity to reducing agent concentration (Figure 3.5B),
PRC2 activity is strongly stimulated by DTT (Figure 4.3D). The drastically different
behavior of Dot1L and PRC2 histone methyltransferases in the presence of reducing
agents may be due to the presence of the cysteine-rich “pre-SET” domain (Figure 4.2) in
Ezh2 but absence of a similar motif in Dot1L. In the absence of reducing agents,
cysteines in this domain may form disulfide bonds that are unfavorable for SET domain
catalytic activity or nucleosomal substrate binding. Unfortunately, at DTT concentrations
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compatible with ssUb nucleosomes (0-10 µM), PRC2 activity is several orders of
magnitude below maximal activity and very close to the background auto-methylation
activity level. Thus, one unexpected challenge I confronted was the need to optimize
PRC2 activity with reducing equivalents without altering the ubiquitin linkage of the
H2Aub substrates being used in these crosstalk experiments (see below).

4.6

In vitro enzymatic ubiquitylation of H2A for PRC2 crosstalk studies3
Having found H2AssUb nucleosomes to be an unsuitable substrate for PRC2

assays (Figure 2.11, Figure 4.3D), and struggling to generate “nearly native” H2Aub
(Chapter 2.2.1), I instead pursued in vitro enzymatic means to generate nucleosomes
containing H2Aub. The Polycomb Repressive complex 1 (PRC1) protein Ring1B is the
major E3 ligase for H2AK119ub in vivo and can efficiently ubiquitylate H2A in vitro. As
for Ezh2, Ring1B catalytic activity is strongly enhanced by association with a Polycomb
Repressive Complex member. A structural study suggested that fellow PRC1 member
Bmi1 enhances Ring1B activity by stabilizing the interaction between the E2 ligase,
Ring1B, and the substrate nucleosome (Li et al., 2006). Additionally, Bmi1 directs selfubiquitylation of Ring1B in the form of atypical-mixed chains that are necessary for H2A
monoubiquitylation activity (Ben-Saadon et al., 2006). For the following in vitro
ubiquitylation reactions, full-length human Ring1B-6xHis and GST-Bmi1 proteins were
co-expressed in E. coli and Ring1B/Bmi1 complex purified by tandem-affinity
chromatography performed by Dr. Ronen Sadeh.
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
3	
  The work in this section was performed with the collaboration of Dr. Ronen Sadeh in
the Laboratory of Chromatin Biology and Epigenetics at The Rockefeller University.	
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In vitro ubiquitylation of nucleosomal H2A was performed with Ring1B/Bmi1
(E3), UbcH5c (E2), E1, monoubiquitin, and ATP. ATP can be purchased as a salt with
several different cations, but for these studies only ATP-Mg was used to accommodate
subsequent PRC2 activity assays (Figure 4.4A). Mg2+ has a stimulatory effect on PRC2
activity, while Li+ has an inhibitory effect (Figure 4.3B,C)
Briefly, designer nucleosomes of two types, either WT or with H2AK118,119
mutated to arginines (H2A_RR), were incubated with active (+ E1) or inactive (- E1)
ubiquitylation

machinery.

Using

active

machinery,

nearly

all

WT

H2A

is

monoubiquitylated, while only trace amounts of H2A_RR was ubiquitylated (Figure
4.4B,C). Western blot analysis with an antibody specific for H2AK119ub confirmed that
H2AK119 is the major ubiquitylation site using this in vitro enzymatic ubiquitylation setup. To further confirm the site-specificity, mass spectrometry analysis was performed by
Joe Fernandez at The Rockefeller University Proteomics Resource Center. This analysis
confirmed that H2AK119 is the major ubiquitylation site, with some minor H2AK118
ubiquitylation, and trace amounts of H2AK36 and H2AK95 ubiquitylation.
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Figure 4.4

H2A ubiquitin ligase machinery inhibits PRC2 MTase activity. In

order to test for potential H2Aub crosstalk with PRC2, sequential ubiquitin ligase and
methyltransferase

reactions

were

performed

on

human

WT

or

H2A_RR

mononucleosomes. After completing both reaction steps, each sample was divided to
assess H2A ubiquitylation and H3 methylation (A). B-D) ½ of each sample was used to
assess Ring1B/Bmi1-mediated ubiquitin ligase activity by western blot. E) ¼ of each
reaction was spotted onto P81 filter paper, washed and PRC2-mediated incorporated 3HCH3	
   was	
   quantitated	
   by	
   scintillation	
   counting.	
   F) PRC2-mediated methylation of H3
was also assessed by fluorography of ¼ of each sample separated on an SDS-PAGE gel.
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Figure 4.4
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4.7

H2A ubiquitylation machinery inhibits PRC2 methylation of H3K27
As described above, H2Aub mononucleosomes can be generated by in vitro

enzymatic ubiquitylation. Using sequential ubiquitylation and methylation reactions, I
sought to test whether the presence of H2Aub affects PRC2 activity in vitro (Figure 4.4).
H2A_RR nucleosomes were used as a control for nucleosomes ubiquitylated on sites
other than H2AK118,119, and (-) E1 reactions were used as a control for effects not
attributable to an active ubiquitylation machinery. After sequential ubiquitylation and
methylation reactions, the samples were split to assay for levels of H2Aub and for
H3K27methylation (Figure 4.4A).
As shown by anti-H2A western blot signal, H2A in WT nucleosomes was nearly
quantitatively ubiquitylated (Figure 4.4C). Ubiquitylation was E1-dependent, and no
appreciable ubiquitylation of H2A_RR was detected.
As expected, in the absence of ubiquitylation machinery WT and H2A_RR
nucleosomes were found to be equally good substrates for PRC2 MTase (Figure 4.4E-F,
compare lanes 1 and 4). Surprisingly, addition of “inactive” ubiquitin ligase machinery
(Ring1B/Bmi1, E2, Ub, ATP, but missing E1) strongly inhibited PRC2 activity. Free
ubiquitin and ATP have no effect on PRC2 activity (not shown), but several groups have
reported stable nucleosome binding activity of Ring1B/Bmi1. Perhaps pre-incubation of
nucleosomes with Ring1B/Bmi1 blocks access of PRC2 to the nucleosome or to H3K27
specifically, thereby explaining the inhibition of PRC2 activity following nucleosome
incubation with inactive ubiquitylation machinery.
Interestingly and curiously, “active” ubiquitylation machinery (+ E1) inhibited
PRC2 activity even further. However, this inhibition was not dependent on ubiquitylation
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of H2AK119 because the same effect was observed on WT and H2A_RR nucleosomes
(Figure 4.4E,F). Western blots to determine whether components of PRC2 are
ubiquitylated in this assay were inconclusive (not shown), and therefore it cannot be ruled
out that ubiquitylation of a PRC2 component by Ring1B may directly inhibit PRC2
MTase activity on H3. However, even with these uncertainties, there is no in vivo
evidence that PRC1 activity inhibits PRC2 mediated H3K27methylation.

4.8

H2Aub modestly inhibits PRC2 activity
Very near the completion of this thesis, “nearly native” Xenopus H2Aub(G76A)

became available thanks to the work of Dr. Beat Fierz (Chapter 2.2.2). This reagent,
paired with xlH2Bub(G76A) (Chapter 2.1), allowed me to test whether the antagonistic
crosstalk between H2Aub and H2Bub on methylation of H3K4 is mirrored in antagonistic
crosstalk on PRC2-mediated methylation of H3K27 (Figure 4.1). To my knowledge
these experiments are the first to investigate potential PRC2 crosstalk with histone
ubiquitylation.
However, H2Aub modestly, but reproducibly, inhibits PRC2 MTase activity
(Figure 4.5). This was an unexpected result since both H3K27me and H2Aub are
transduced by Polycomb Repressive Complexes (PRC2 and PRC1, respectively) with
well-established roles in gene repression. However, several recent publications provide
evidence that the functional link between H2Aub and transcriptional repression is not as
clear as was once thought (Eskeland et al., 2010; Richly et al., 2010; Scheuermann et al.,
2010), and these will be discussed further in Chapter 6.
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Figure 4.5 H2Aub inhibits PRC2 methyltransferase activity on
mononucleosomes. PRC2 methyltransferase activity was tested in reducing
conditions on Xenopus unmodified and H2Aub(G76A) mononucleosomes. A
representative experiments is shown. Reactions were separated by SDS-PAGE,
Coomassie stained, and activity assessed by fluorography (A). Automethylation
activity is indicated (*). Activity was also assessed by scintillation counting of
incorporated 3H into ! of each reaction (B). Error bars indicate the standard
deviation of multiple scintillation counts of the same reaction. Paired student’s test
is indicated, p<0.0001 (**).

4.9

Presence of H2Bub in nucleosome doesn’t appreciably influence PRC2

activity
As described in Chapter 3, nucleosomes containing H2BK120ub directly
stimulate Set1 and Dot1 histone methyltransferase activity directed towards H3K4 and
H3K79 respectively. However, it is still far from clear how monoubiquitylation on
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H2BK120 stimulates both of these enzymes. Set1 and Dot1 are both histone lysine
methyltransferases, but they are evolutionarily unrelated. Set1 activity requires the
participation of its complex members while Dot1 is an active MTase on its own and is not
known to belong to a stable protein complex. Perhaps H2Bub is a general stimulator of
HMTases. Or perhaps its stimulatory action is restricted to MTases involved in
transcriptional activation (e.g. Set1 and Dot1). Further, given the role of H2Bub in active
transcription, perhaps it antagonizes methylation states involved in transcriptional
repression.
To investigate these possibilities, I performed in vitro methyltransferase
experiments

to

test

for

crosstalk

between

H2Bub

and

PRC2-mediated

H3K27methylation. My results show that PRC2 activity is unaffected by the presence of
H2Bub in nucleosomal substrates (Figure 4.6). Based on time course analysis, the
kinetics of methylation also did not appreciably differ between the substrates (Figure
4.6D-E). By this measure also, H2Bub nucleosomes were equally good substrates for
PRC2 as unmodified nucleosomes, ruling out the possibility that nucleosomal H2Bub
represses PRC2-mediated methylation in these assay conditions.
As was outlined above, H2Bub and H2Aub have opposing effects on
methyltransferase activity directed towards H3K4 (Figure 4.1), and I hypothesized that
this may be a more general mechanism of regulating histone methyltransferases. In
particular, PRC2-mediated H3K27methylation was an attractive candidate because of its
antagonistic role to H3K4 methylation in regulating transcription. However, the in vitro
MTase assays presented here suggest that, contrary to expectation, H2Aub inhibits PRC2
while H2Bub had no appreciable effect on MTase activity.
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Figure 4.6 H2Bub crosstalk with HMTases does not extend to PRC2. PRC2
methyltransferase activity was tested on Xenopus (xl) unmodified and H2Bub(G76A)
mononucleosomes under reducing conditions. A-C) ½ of each reaction was separated by
SDS-PAGE and Coomassie stained (A) and activity was assessed by fluorography (B) the
lower panel is a short exposure of the upper panel. Activity was also assessed by
scintillation counting of 3H-CH3 incorporation in ½ of each reaction (C). Error bars
indicate the standard deviation of replicate scintillation counts of the same filter paper. DE) reactions were incubated for the indicated times and the entire reaction assessed by
fluorography.
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Figure 4.6
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H3

CHAPTER 5: TESTING

FOR

CROSSTALK

PHOSPHORYLATION AND H3K27ME3

BETWEEN

H3

VARIANTS,

H3.3

4

As discussed in Chapter 1, multiple mechanisms exist to selectively introduce
complexity into the chromatin fiber. This thesis has thus far emphasized the importance
of histone post-translational modifications and has investigated mechanisms for how
meaningful combinations of modifications are generated and maintained. Site and
process-specific incorporation of variant histone proteins is another major mechanism to
introduce complexity and increase the epigenetic coding potential of chromatin. In this
chapter, H3 variant-specific and phosphomimetic nucleosomes are used in crosstalk
experiments with PRC2 MTase for H3K27.

5.1

Mammalian histone H3 variants
Mammalian cells express three H3 variants, H3.1, H3.2, and H3.3, in addition to

the more divergent centromere-specific variant, CENP-A. The amino acid sequence of
H3.3 differs from the canonical H3.2 and H3.1 proteins at only 4-5 positions (Figure
5.1A) but has distinct chromatin deposition properties. H3.1 and H3.2 expression is
restricted to S-phase and their chromatin deposition is coupled to DNA replication,
whereas H3.3 is expressed constitutively throughout the cell cycle and its deposition is
independent of DNA replication (Ahmad and Henikoff, 2002; Ray-Gallet et al., 2011). In
non-replicating cells, H3.3 replaces canonical H3 in chromatin over time (Pina and Suau,
1987).
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
4
The work in this chapter was performed as part of a collaboration with Dr. Laura
Banaszynski in the Laboratory of Chromatin Biology and Epigenetics at The Rockefeller
University.
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Figure 5.1 Mammalian H3 variants and methyl/phos “switches” on H3. Differential
sequence features of mammalian H3 variants H3.1, H3.2, and H3.3 are shown (A). H3.1 and
H3.2 only differ at one position, 96, whereas H3.3 differs from H3.1 and H3.2 at 4-5 positions,
both in the H3 folded core and in the N-terminal tail. Serine 31, a potential phospho-acceptor
residue, is colored in green to emphasize its restriction to the H3.3 variant and its proximity to
the conserved lysine 27, a methyl acceptor, colored in red. B) outlined are established and
hypothesized methyl/phos switches on the N-terminal tail of H3. Validated interference of
H3S10phos and H3S28phos on HP1 and PcG binding to adjacent methylated lysines, are shown
with black blunt-headed arrows. A hypothesized H3.3S31phos/H3K27me3 “switch” is indicated
with a grey blunt-headed arrow and question mark.

97	
  

Initial studies of H3.3 function linked this histone variant with active
transcription. In the ciliate Tetrahymena thermophila, an H3.3-like protein is specifically
targeted to the transcriptionally active macronucleus but excluded from the highly
compacted and transcriptionally inactive micronucleus (Allis et al., 1980). Subsequent
studies have shown that H3.3 enrichment at actively transcribed regions of the genome is
conserved in multicellular eukaryotes as well (Ahmad and Henikoff, 2002; Goldberg et
al., 2010; Mito et al., 2005). H3.3 is also enriched in constitutive heterochromatin at
telomeres (Goldberg et al., 2010; Wong et al., 2009) and at cis-regulatory elements (Jin
and Felsenfeld, 2006), including PcG binding sites (Mito et al., 2007). It has been
proposed that H3.3 enrichment in particular regions is due in large part to locally high
turnover of nucleosomes (Mito et al., 2007). The mechanism of deposition and functional
significance of H3.3 incorporation at these various classes of genomic regions is an active
area of investigation.

5.2

Histone H3 Methyl/Phos switches
An understudied aspect of H3.3 biology is the significance of having a serine at

position 31, where canonical H3 (H3.1/2) has an alanine (Figure 5.1A). Unlike alanine,
serine is a potential phospho-acceptor residue, and in fact, phosphorylated S31 in H3.3
was identified in mitotically arrested cells (Hake et al., 2005). Although the function of
H3.3S31phos is almost completely unknown, histone phosphorylation on other sites is
clearly linked to critical processes such as mitosis (H3S10phos, H3S28phos, H3T3phos),
apoptosis (H2BS14phos), DNA repair (H2A.XS139phos), and inducible gene activation
(H3S10phos, H3S28phos)(Baek, 2011; Berger, 2010). In the case of H3S10 and H3S28,
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phosphorylation critically disrupts binding of effector proteins to the trimethylated lysine
adjacent to the phosphorylated serine (Figure 5.1B), so called “methyl-phos switches”
(Fischle et al., 2005; Fischle et al., 2003; Gehani et al., 2010; Lau and Cheung, 2011).
HP1-association is a hallmark of constitutive heterochromatin, and binding to
H3K9me3 is critical for proper chromatin localization of HP1. During mitosis, the bulk
of HP1 dissociates from chromatin despite no significant change in H3K9me3 levels on
condensed chromosomes. Adjacent to K9 is S10, which is phosphorylated in M-phase by
Aurora B kinase. HP1 binding to H3K9me3 is incompatible with H3S10phos, and
phosphorylation of H3S10 is sufficient to eject HP1 from chromatin during M-phase
(Fischle et al., 2005; Hirota et al., 2005). Recently, the H3K27/S28 pair was also
discovered to participate in a methyl/phos switch triggered mitogens, stress and
differentiation signals (Figure 5.1B). Phosphorylation of H3S28 by MSK1 at promoters
of PcG-repressed genes disrupts PRC1 and PRC2 binding and results in a reduction of
H3K27me3 and transcriptional de-repression (Gehani et al., 2010; Lau and Cheung,
2011).
Almost nothing is known about the function of the H3.3 variant-specific S31phos,
but its proximity to H3K27 hints that it may impact PRC2-mediated methylation of
H3K27. We wondered whether K27/S31 might function as a methyl/phos switch similar
to K9/S10 and K27/S28.
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5.3

Testing for differential PRC2 MTase activity on canonical H3.2 and H3.3

nucleosomes
Dr. Laura Banaszynski, a post-doctoral fellow in the Allis lab, has been studying
the function of H3.3 in lineage specification during ESC differentiation. In agreement
with studies linking H3.3 with active transcription, she found H3.3 mononucleosomes in
ESC to be enriched in H3K4me3 and depleted in H3K27me3 relative to H3.1
mononucleosomes. However, in the absence of H3.3, transcription of a subset of
developmental genes is upregulated, accompanied by reduced PcG occupancy and
reduced H3K27me3 at the promoters of these genes. Taken together, these data suggest
that at least for some genes, H3.3 is important for PcG-mediated transcriptional
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Figure 5.2 H3.2 and H3.3 designer octamer and mononucleosomes. Octamers containing
core histones H3.2, H3.3, H3.2_K27R, H3.3_K27A, H3.2_A31E, or H3.3_S31E were assembled
and incorporated into mononucleosomes as described in Chapter 2.4,5. Coomassie stained
SDS-PAGE gel of octamers (A) and EtBr stained native PAGE gel of mononucleosomes, MN
(B).
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We wanted to test whether H3.3 nucleosomes are intrinsically better substrates for
PRC2-mediated H3K27methylation than canonical H3 nucleosomes. To do so, I
assembled a set of designer human octamers with either H3.2, H3.3, or with point
mutants at the PRC2 methylation site, H3.2_K27R, H3.3_K27A (Figure 5.2A). Note that
the H3.2 octamers used in this chapter are identical to the unmodified octamers described
in Chapter 2 and used in crosstalk studies in Chapters 3 and 4. Mononucleosomes were
assembled with these octamers and 153bp (601) DNA (Figure 5.2B), as described in
Chapter 2.5.
In methyltransferase assays with 3H-SAM, H3.3 nucleosomes were found to be
slightly better substrates for PRC2 MTase than canonical H3.2 nucleosomes (Figure 5.3).
This difference is indeed subtle, but was reproducible across different mononucleosome
assemblies, time course of MTase reaction, and over a 4-fold change in
PRC2:nucleosome molar ratio (Figure 5.3A-C).
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Figure

5.3

Putative

H3K27methylation.

H3

variant-specific

Mononucleosomes

crosstalk

containing

with

H3.2,

PRC2-mediated

H3.3,

H3.2_K27R,

H3.3_K27A, H3.2_A31E, or H3.3_S31E were used in methyltransferase assays with 3HSAM (or cold SAM (D)) and PRC2. Activity was assessed by fluorography (A, B, F) or
scintillation counting of incorporated

3

H-CH3 (C, G). As expected, no

3

H-CH3

incorporation was observed on nucleosomes containing H3.2_K27R or H3.3_K27A (A,
F, G). PRC2 MTase activity was shown to be slightly, but reproducibly, higher on H3.3
containing nucleosomes using different reaction times (B), enzyme concentration (C),
and nucleosome assembly batches (A-C, F, G). D), mass spectrometry analysis was
performed on methyltransferase samples to assess whether the relative proportion of
H3K27Kme0,1,2,3 differed between H3.2 and H3.3. Numbers represent the percent of
H3K27 in the given methylation state after incubation with PRC2 and SAM. Red boxes
around the percent unmodified and the percent dimethylated highlight differences in
PRC2 activity and processivity on H3.2 and H3.3 nucleosomes. Chemical structures of
phosphoserine and the phosphoserine-mimetic, glutamic acid, are shown in (E).
Incorporation of glutamic acid at position 31 reduced PRC2 activity to about 60% of its
activity on WT H3.2 and H3.3 nucleosomes (F, G).
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In vitro core-PRC2 enzymatic activity assays (Nekrasov et al., 2007; Sarma et al.,
2008) show that H3K27me1 is the predominant methylation state produced in vitro. We
wondered whether increased 3H3C incorporation on H3.3 nucleosomes was the result of
increased processivity of PRC2 in converting monomethyl to di- and trimethyl, or
whether it was the result of increased monomethylation only. To measure the distribution
of K27me1, me2, and me3 on H3.2 and H3.3, the products of PRC2-mediated
methylation reactions were subjected to mass spectrometry. As expected, H3K27me1 is
the predominant methylation state observed for both H3.2 and H3.3 containing
nucleosomes. Interestingly, preliminary analysis revealed that enhanced activity on H3.3
nucleosomes was likely due to the incorporation of higher order methylation, as
H3K27me2 was only significantly observed on this substrate (Figure 5.3D). As described
above, H3.2 and H3.3 amino acid sequences differ at only 4 positions: position 31 in the
N-terminal tail, and 3 positions within the histone fold domain (Figure 5.1A). The
proximity of position 31 to K27 makes it a good candidate for potential regulation of
enzymatic activity on K27. Future experiments using H3.2_A31S nucleosomes will test
whether a serine at position 31 is sufficient for increased higher order K27methylation in
vitro. Alternatively, it is possible that amino acid differences in the histone fold domain
of H3.2 and H3.3 might affect nucleosomal stability in a way that affects PRC2 MTase
processivity.
If H3.3 facilitates higher order methylation of H3K27 in vivo, then it may have an
impact on gene regulation. Based on peptide and nucleosome binding studies, one would
expect PcG binding to H3K27me1 chromatin to be significantly less than to
H3K27me2/3 chromatin (Bernstein et al., 2006; Margueron et al., 2009), and H3K27me1
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is unable to allosterically stimulate PRC2 methyltransferase activity (Margueron et al.,
2009). Taken together, these data may point to a role of H3.3 in tuning PcG-mediated
transcriptional repression.

5.4

Putative methyl/phos switch between K27me and H3.3S31phos
Having shown that H3.3 nucleosomes are intrinsically slightly better substrates

for PRC2 methylation than canonical H3 nucleosomes, we wondered whether
phosphorylation at S31 in H3.3 might also influence PRC2 activity. Might H3.3S31phos
participate in a methyl/phos switch with PRC2 and H3K27me3 (Figure 5.1B)?
In order to begin to address this question, H3.2 and H3.3 recombinant proteins
carrying the serine-phosphomimetic glutamic acid (Figure 5.3E) were incorporated into
designer octamers and assembled into designer nucleosomes (Figure 5.2). Strikingly, the
presence of glutamic acid at position 31 inhibited PRC2 methylation activity significantly
on both H3.2 and H3.3 mononucleosomes (Figure 5.3F,G). The slightly increased signal
still observed on the mutant H3.3 nucleosomes with respect to their H3.2 counterparts
suggests that amino acid differences in the core, and not only at position 31, contribute to
enhanced PRC2 methyltransferase activity.
In summary, studies on the function of H3.3 in mouse lineage determination led
to the identification of a putative H3 variant-specific methyl/phos regulatory link,
although mechanistic details remain unclear. We look forward to knowing whether the
observed in vitro inhibition of PRC2 by a phosphomimetic at position 31 will extend to
phosphorylated H3.3 and whether the in vitro crosstalk identified in this chapter will be
validated in vivo.
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CHAPTER 6: DISCUSSION
Chromatin is the biological substrate for all DNA-templated processes, including
transcription, mitosis, meiosis, DNA replication, and DNA repair. The diversity of
processes regulated by chromatin is mirrored by the immense structural and
compositional complexity of chromatin itself (Chapter 1.1). Even mononucleosomes, the
minimal repeating units of chromatin, are endowed with extensive variation in the form
of variant histone incorporation and a multitude of histone PTMs. It is of central
importance to understand how variation in the chromatin fiber, signal transduction
pathways, and all types of DNA metabolism are coordinately regulated to produce
functional outcomes, and conversely, how misregulation results in disease.

6.1

Designer

ubiquitylated

nucleosomes

to

study

crosstalk

with

methyltransferases
An important mechanism of regulatory coordination is histone PTM crosstalk:
enzymatic installation or removal of a histone PTM that is influenced by pre-existing
PTMs. In theory, a pre-existing PTM can influence enzymatic activity in cis and in trans
(Figure 1.2). For example, a histone PTM may interact in trans with a modificationspecific binding domain in the enzyme or its associated complex. Interactions of this type
may lend specificity and/or affinity to the enzyme’s interaction with chromatin and may
be particularly important for processive enzymes, like many MTases (Walsh, 2006).
Conversely, a PTM may block enzyme association with its nucleosome substrate or
inhibit the precise positional binding required for productive enzymatic activity.
Alternatively, a PTM may function in cis by altering the biophysical properties of the
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nucleosome or the chromatin fiber, making nucleosomes more dynamic for example, or
the fiber less compact. These differences may expose surfaces or target residues in a way
that influences enzymatic activity.
The inherent heterogeneity of histones and nucleosomes purified from
endogenous sources has historically obstructed efforts to confirm that observed in vivo
crosstalk is mediated directly by a particular PTM. Recently several groups have
developed chemical strategies for robust and site-specific installation of histone PTMs
(Chatterjee and Muir, 2010). Chemically-defined histones bearing desired modifications
can be reconstituted into designer nucleosomes, which can serve as potentially powerful
substrates in enzymatic crosstalk studies (Allis and Muir, 2011).
One leader in designer chromatin methodologies is the lab of Dr. Tom Muir, at
Princeton University, with whom I’ve been fortunate to collaborate throughout my thesis
research. Among other advances, they were the first to adapt chemical ligation techniques
to generate H2B homogenously monoubiquitylated at K120, requiring demanding semisynthetic peptide chemistry and two chemical ligation steps (McGinty et al., 2008).
Using designer mononucleosomes, Dr. McGinty and colleagues were able to
conclusively show that H2Bub can directly stimulate Dot1L-mediated H3K79
methylation (McGinty et al., 2008), an in vivo crosstalk relationship first revealed in
striking fashion by yeast genetics (Briggs et al., 2002; Ng et al., 2002b). It had been
suggested that in vivo Dot1 is stimulated indirectly by H2Bub, perhaps by serving as a
“wedge” between adjacent nucleosomes and thereby exposing the nucleosome axial
surface, where H3K79 resides (Figure 1.3), for methylation. But since the in vivo
crosstalk relationship was recapitulated in vitro using mononucleosome substrates,
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H2Bub-mediated chromatin fiber decompaction is unlikely to be the main mechanism of
stimulation. Designer nucleosomes were also utilized to show that H2Bub can directly
stimulate Set1-mediated H3K4 methylation (Kim et al., 2009), another in vivo crosstalk
relationship first revealed by yeast genetics (Briggs et al., 2002; Dover et al., 2002; Sun
and Allis, 2002).
Interestingly, Dot1 and Set1 are evolutionarily unrelated, and the local structural
environments of their target lysines are very different (H3K79 being located on the axial
surface of the nucleosome and H3K4 being located near the end of the relatively
unstructured H3 N-terminal “tail”)(Figure 1.3). These observations elicit the question,
how are the activities of both Set1 and Dot1 drastically stimulated by the presence of
H2Bub in the nucleosome substrate?
Recently, using nucleosomes reconstituted with endogenous H2Aub or H2A,
Nakagawa and colleagues showed that deubiquitylation of H2Aub allowed for efficient
methylation of H3K4 by the HMTase MLL3 complex (Nakagawa et al., 2008),
suggesting that H2Aub, in addition to H2Bub, also participates in enzymatic crosstalk
with histone MTases, albeit of an inhibitory nature and antagonistic to transcription. This
study in combination with the H2Bub/H3K79me and H2Bub/H3K4me crosstalk studies
suggested that it may be a general feature of histone ubiquitylation to participate in
enzymatic crosstalk with histone methyltransferases.

6.2

Summary and discussion of experimental results
For this thesis I was interested in exploring the specificity and range of crosstalk

relationships between histone monoubiquitylation and histone methyltransferases. For
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this purpose I utilized expressed protein ligation and disulfide-mediated ubiquitylation
strategies to generate sufficient quantities of chemically-defined H2AK119ub and
H2BK120ub (Chatterjee et al., 2010; McGinty et al., 2008; McGinty et al., 2009b)
(Chapter 2). In order to isolate putative direct enzymatic crosstalk functions of these
modified histones, rather than indirect effects on chromatin higher-order structure that
manifest in enzymatic activity differences, I chose mononucleosomes as substrates for
these studies. As noted above, H2Bub and H2Aub have opposing influences on
methylation of H3K4 in vitro. I wanted to test whether H2Aub also functions
antagonistically to H2Bub in crosstalk with other HMTases, specifically Dot1L (Chapter
3) and PRC2 (Chapter 4). The main results of these experiments are summarized below
and in Figure 6.1A.
Dot1L MTase activity in vitro is stimulated by nucleosomal monoubiquitylation
at several positions (Figure 3.1), notably those in the “stimulatory patch” on the
nucleosome axial surface and at a radial site (Chatterjee et al., 2010; McGinty et al.,
2008; Wu et al., 2011). This reveals extensive plasticity in the ubiquitin-mediated
stimulation mechanism of Dot1L. Using H2AssUb nucleosomes I tested whether this
positional-plasticity of stimulation extended to H2AK119. The in vivo abundance of
H2AK119ub (5-15% of H2A)(Goldknopf and Busch, 1977; West and Bonner, 1980) and
its nucleosomal location, nearly as far away from the stimulatory patch as possible
(Figure 3.1A), made it an interesting test case for Dot1L stimulation.
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Figure 6.1 Summary of direct enzymatic crosstalk experiments (Chapters 3-5).
The results of enzymatic crosstalk studies between designer nucleosome substrates and MTases
for H3K79, H3K4, and H3K27 are depicted in grid form. Text in black represents results
obtained and published by others. Text in blue represents as of yet unpublished results presented
in this thesis. Text inside the boxes indicates the relevant MTase, citation or thesis chapter, and
type of crosstalk, if any, relative to activity on unmodified nucleosomes. A) the results of crosstalk experiments with MTases for H3K79, H3K4, and H3K27 (top) utilizing monoubiquitylated
nucleosomes on H2BK120 or H2AK119 (left) as presented in Chapters 3-4. B) the results of
crosstalk experiments with MTases for H3K27 (top) utilizing nucleosomes assembled with either
the H3 variant H3.3 or H3.3 containing serine to glutamate substitution at position 31(left) as
presented in Chapters 5.
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Experiments presented in Chapter 3 did not reveal any crosstalk between H2Aub
and Dot1L, suggesting that H2AK119ub is unlikely to be able to substitute for
H2BK120ub in Dot1L stimulation in vivo, nor is it likely to repress Dot1L activity on
nucleosomes doubly modified by H2Aub and H2Bub, as may exist near DNA double
strand breaks (Bekker-Jensen and Mailand, 2011). An important unanswered question
regarding Dot1L regulation is how ubiquitylation at a variety of sites, but not at
H2AK119, is able to stimulate MTase activity.
In Chapter 4 I turned my attention to another MTase, PRC2, to test whether
crosstalk between histone ubiquitylation and histone methylation extends to a critical
MTase for repression of developmentally regulated genes (Margueron and Reinberg,
2011). In particular, I was interested in whether the antagonistic crosstalk between
H2Aub and H2Bub on methylation of H3K4 (strongly linked to active transcription) is
mirrored in antagonistic crosstalk on PRC2-mediated methylation of H3K27 (strongly
linked with transcriptional repression).
H2Aub is typically understood to cooperate with PRC2-mediated H3K27
methylation in transcriptional repression. Therefore I hypothesized that H2Aub may
stimulate PRC2 activity on H3K27, analogously to H2Bub stimulation of Set1
methylation of H3K4. However, I found that H2Aub produces a modest, but
reproducible, inhibition of PRC2 activity in vitro (Figure 4.5).

One more trivial

explanation for this finding might be that the relatively close proximity of H2AK119ub to
H3K27 in the nucleosome (Figure 1.3) may simply sterically hinder PRC2
methyltransferase activity. While this possibility cannot be ruled out by my studies,
recently published data from several groups suggest that the widely-accepted link
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between H2Aub and transcriptional repression may not be so straightforward (Eskeland
et al., 2010; Richly et al., 2010; Scheuermann et al., 2010).
Eskeland and colleagues showed that the H2A E3 ligase activity of Ring1B is
dispensable for transcriptional repression of Polycomb target genes and for long-range
chromatin compaction of Hox gene clusters in vivo (Eskeland et al., 2010). In light of our
in vitro results, it would be of interest to know whether cells with catalytically null
Ring1B have attenuated or otherwise misregulated activation of Hox genes during
differentiation.
Scheuermann and colleagues identified a novel Polycomb repressive complex in
Drosophila with H2A deubiquitinase activity, PR-DUB (Scheuermann et al., 2010).
Interestingly, they found that H2A deubiquitinase activity is required for proper
transcriptional repression of Polycomb target genes in vivo. Further, repression of
Polycomb target genes is even more severely compromised if dRing, E3 ligase for
H2Aub, and PR-DUB are simultaneously depleted. Therefore, at least in Drosophila,
complexes with directly opposing enzymatic activities on H2A synergistically regulate
transcriptional repression. These results suggest that H2Aub in different genomic
locations may have opposite influences on transcription or that dynamic cycles of H2A
ubiquitylation and deubiquitylation may be required for proper gene repression. I look
forward to studies that will investigate how the spatial, temporal and kinetic control of
H2Aub turnover on chromatin contributes to gene regulation. Such studies would greatly
inform future in vitro studies using designer chromatin that more closely mimic the
dynamism of histone ubiquitylation in vivo.
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Lastly, Richly and colleagues identified ZRF1 as an H2Aub binding protein
involved in differentiation-dependent transcriptional activation of Polycomb target genes
(Richly et al., 2010). If reduced PRC2 activity on PcG-repressed gene is an important
early step in pushing the chromatin state towards one more permissive to transcription,
then my in vitro crosstalk data may provide another layer of mechanistic explanation for
H2Aub involvement in transcriptional de-repression.
Next, using “nearly native” H2Bub(G76A) nucleosomes, PRC2 was shown to be
equally active on unmodified and H2Bub mononucleosomes, hinting that crosstalk
between H2Bub and MTases may be limited to those that are involved in active
transcription, such as Set1 and Dot1L.

The molecular basis of this selectivity is

completely unknown at this point but of great interest.
The crosstalk studies presented in this thesis were limited to Dot1L and PRC2
MTases, but a great strength of the “nearly native” chemically defined ubiquitylation
method is their suitability for crosstalk studies with other enzymes that require reducing
agents, either directly for their catalytic activity, or indirectly for the proper
structure/architecture of their catalytic complex. In particular, I have an interest in how
H2Aub and H2Bub may crosstalk with chromatin remodeling enzymes. Additionally,
reconstituted chromatin containing “nearly native” H2Aub and H2Bub could also be used
as bait to discover new crosstalk relationships and even new enzymatic activities on
chromatin. For example, nuclear extract fractions could be screened for enzymatic
activities (such as SAM or Acetyl CoA incorporation, for methylation and acetylation
activities, respectively) that are specific for, or modulated by, nucleosome substrates
containing H2Aub, H2Bub. This kind of enzymatic screen could open up new avenues to
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pursue in investigations of histone ubiquitylation function. Of course, similar screening
approaches to identify novel activities and crosstalk pathways could also be pursued with
other types of designer chromatin as well.
In Chapter 5, crosstalk studies with PRC2 were extended to designer nucleosomes
containing either canonical histone H3.2, the variant histone H3.3, or genetically encoded
H3 phosphoserine mimetics. These studies were done in collaboration with Dr. Laura
Banaszynski, a post-doctoral fellow in the Allis lab, who has been studying the function
of H3.3 in lineage specification during embryonic stem cell differentiation. In the absence
of H3.3, she observed that transcription of a subset of developmentally regulated genes is
upregulated, accompanied by reduced PcG occupancy and reduced H3K27me3 at the
promoters of these genes (unpublished). Her data suggest that at least for some genes,
H3.3 is important for PcG-mediated transcriptional repression, perhaps at the level of
crosstalk with PRC2. However, in vitro PRC2 MTase activity on H3.3 nucleosomes was
found to be only slightly higher than on H3.2 nucleosomes, suggesting that intrinsic
differences between mononucleosomes containing canonical versus variant histone H3
are unlikely to explain the gene expression differences she observed in vivo.
Interestingly, H3.3 is enriched in parts of the genome that experience higher than
average nucleosome turnover including cis-regulatory elements such as PcG binding sites
(Jin and Felsenfeld, 2006; Mito et al., 2007). This property of H3.3-enriched chromatin
cannot be mimicked using my designer mononucleosomes. Perhaps, in some yet
unknown way, the biophysical characteristics of some cis-regulatory element chromatin
facilitate PcG-association and PRC2-mediated methylation of H3K27. If so, then
upregulation of these developmentally regulated genes may be due not to the lack of H3.3
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per se, but rather due to the changes in chromatin structure and dynamics that result from
lacking H3.3-specific nucleosome turnover.
In addition to their differential genomic localization (Ahmad and Henikoff, 2002;
Goldberg et al., 2010; Jin and Felsenfeld, 2006; Mito et al., 2005), and in vivo turnover
properties (Mito et al., 2007), H3.3 differs from canonical H3.2/1 in having a serine at
position 31 rather than an alanine (Figure 5.1). Interestingly, H3.3S31phos was identified
in mitotically arrested cells (Hake et al., 2005), but very little is known about the function
of this histone variant-specific PTM in mitosis or in any other cellular process. However,
the proximity of S31 to H3K27 hints that phosphorylation at this position may participate
in crosstalk with PRC2-mediated methylation of the nearby H3K27. Given that
phosphorylation on H3S10 and H3S28 disrupts binding of effector proteins to the
adjacent trimethylated lysine (H3K9me3 and H3K27me3, respectively) (Fischle et al.,
2005; Gehani et al., 2010; Lau and Cheung, 2011), we hypothesized that PRC2 activity
on H3K27 may be inhibited by phosphorylation on S31.
To begin to follow this hypothesis, designer nucleosomes were assembled with
H3.3 or H3.3 carrying a substitution of glutamic acid at position 31 (H3.3_S31E) to serve
as a phosphoserine mimetic. These mononucleosomes were compared as substrates for
PRC2-mediated methylation of H3K27, the results of which are summarized in Figure
6.1B. PRC2 was found to be only about 60% as active on H3.3_S31E mononucleosomes
as compared to WT H3.3 mononucleosomes.
The crystal structures of Eed in complex with trimethylated H3 peptides give few,
if any, clues as to whether glutamic acid at position 31 would directly disrupt PRC2
binding to the N-tail of H3 (Margueron et al., 2009), and not enough is known about the
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mechanism of H3K27me3-mediated allosteric stimulation of Ezh2 to infer whether
glutamic acid (or phosphorylation) at position 31 in H3.3 might affect this aspect of
PRC2 MTase regulation. Future studies will address these issues.
Future studies will address whether the observed in vitro inhibition of PRC2 by a
phosphoserine mimetic at position 31 extends to phosphorylated H3.3S31 and whether
this in vitro crosstalk identified will be validated in vivo as a novel, H3.3 specific
methyl/phos switch.

6.3

Concluding remarks
When starting from observations made in vivo, the compositional and structural

complexity of endogenous chromatin can make it difficult to assign mechanistic function
to a particular variable. Therefore, the ability to generate substrates for chromatinmediated processes that have reduced complexity can be a powerful tool. Throughout the
text I have highlighted several success stories of the designer chromatin approach.
However, the reductionist strength of designer chromatin can also be a weakness.
This thesis made use of designer mononucleosomes, and others have successfully
generated designer nucleosome arrays, but even with arrays it is difficult to mimic the
dynamic remodeling present in endogenous chromatin. Particularly relevant to this thesis,
cycling of ubiquitylation on H2A and H2B through the action of ubiquitin ligases
(E2/E3s) and deubiquitylating enzymes (DUBs) is important for transcriptional
regulation (Daniel et al., 2004; Fleming et al., 2008; Henry et al., 2003; Pavri et al., 2006;
Scheuermann et al., 2010; Wyce et al., 2007). This dynamism would be hard to mimic
using designer chromatin, at least with the tools currently available.
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Furthermore,

preparing designer chromatin reagents is often a significant investment on the part of a
researcher, and therefore it is an approach that should be undertaken with prudence and
with a constant eye on in vivo evidence for the particular hypothesis to be tested in vitro.
Additionally, better descriptive knowledge of the chromatin states that exist in
vivo would be very valuable in informing the most worthwhile experiments to pursue in
vitro. For example, which histone PTMs, histone variants, or chromatin-associated
proteins are specifically enriched in H2Aub and H2Bub-containing chromatin in vivo,
and which are depleted? This kind of knowledge would be a good starting point for
subsequent studies of H2Aub and H2Bub function, including future direct enzymatic
crosstalk studies with designer chromatin.
In conclusion, the studies presented in this thesis contribute towards efforts to
predict crosstalk relationships between pre-existing modifications on nucleosome
substrates and enzymes. Increased understanding of crosstalk relationships will further
the long-term goal to understand how histone PTMs and other sources of structural
complexity in chromatin are coordinately regulated to generate meaningful combinations
at physiologically appropriate genomic locations, and eventually to understand how these
combinations of chromatin structural features are “read” by the cell.
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METHODS
Recombinant human histone expression and purification
Recombinant human histones were expressed and purified essentially according
to Ruthenburg et al., 2011 (Ruthenburg et al., 2011). Briefly, N-terminal hexahistidine
tagged human H3.2_C110A, H4, H2A.a4, H2A.a4_K119C H2B.k, and H2B.k_K120C
were expressed in BL21(DE3) E. coli and solubilized from inclusion bodies with 6M
guanidinium chloride and 500 mM NaCl. After denaturing Ni-NTA (QIAGEN)
purification, histones were dialyzed into cleavage buffer: 10 mM MOPS pH 7, 500 mM
NaCl, 10% glycerol, 0.5 mM EDTA, 5 mM beta-mercaptoethanol (b-ME). Hexahistidine
tags were cleaved off by addition of TEV (for H3.2, H4, H2A) or Precision protease (for
H2B), and tagless histones were purified by denaturing Ni-NTA subtractive-purification.
For long-term storage of purified histones the denatured flow through was desalted over
PD-10 columns in 100-200 mM trimethylammonium acetate (TMAA) pH 5.0 before
lyophilization.
The integrity of the eventual disulfide bond between H2AK119C, H2BK120C
and ubiquitin-aminoethanethiol (Ub-aminoethanethiol) is extremely sensitive to reducing
agents. Note that many other published protocols using His-tagged recombinant histones
employ TEV and/or Precision cleavage during octamer assembly. However, because
these proteases require reducing conditions for activity, they are not compatible with
octamer assemblies including disulfide-mediated ubiquitylated histones. Careful removal
by extensive dialysis and/or reverse-phase HPLC purification of any residual reducing
agents from all histone preps (not only H2AK119C and H2BK120C) is crucial.
Additionally, the use of β-ME in the purification and cleavage steps results in the
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formation of β-ME-H2AK119C or β-ME-H2BK120C adducts, which were reduced with
20 mM Tris(2-carboxyethyl)phosphine) (TCEP) at pH 8.5 and RP-HPLC purified before
use in H2AssUb or H2BssUb ligation reactions.

H2AssUb and H2BssUb preparation
Disulfide-directed ubiquitylation of histones H2A and H2B was carried out
essentially according to Chatterjee et al., 2010. The most notable alteration to the
published protocol was the use of 2,2’-dithiobis(5-nitropyridine) (DTNP) to
protect/activate the sulfhydryl on the Ub-aminoethanethiol adduct rather than
protect/activate the sulfhydryl of the cysteine at position 119 in H2A or at position 120 in
H2B.
As described in Chatterjee et al., full length ubiquitin was expressed in E. coli
BL21(DE3) as a GyrA intein-chitin binding domain (CBD) fusion protein. Soluble
ubiquitin fusion protein was purified on chitin resin, and ubiquitin cleaved off the resin
with 50 mM cystamine-dihydrochloride, 50 mM TCEP at pH 7.5. Ubiquitin with the
desired C-terminal aminoethanethiol linker was further purified by C18 RP-HPLC over a
25-60% B gradient: gradient: (A) 0.1% trifluoroacetic acid (TFA) in water, (B) 90%
actetonitrile, 0.1% TFA in water.
To protect/activate the C-terminal sulfhydryl of purified Ub-aminoethanethiol, an
asymmetric disulfide with DTNP was generated. In a typical reaction, approximately 5
mg of DTNP dissolved in 1.5 mL acetic acid was mixed with approximately 3 mg of Ubaminoethanethiol dissolved in 0.5 mL water. The reaction was allowed to proceed,
shielded from light, for 18-24 hours at 25° C. As the DTNP reacts with Ub-
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aminoethanethiol, 2-thio-5-nitropyridine (TNP) is released, which has a bright yellow
color. After incubation, the now neon yellow colored solution, was dialyzed in a Slide-ALyzer, 3.5kDa MWCO (Pierce) against water to precipitate unreacted DTNP. The desired
Ub-aminoethanethiol-5-nitro-2-pyridinesulfenyl (Ub-aminoethanethiol-pNpys) product
was then purified by semi-preparative C18 RP-HPLC over a 30-50% B gradient.
Purified Ub-aminoethanethiol-pNpys was mixed at approximately 3:1 molar ratio
with histone (either H2AK119C or H2BK120C) in a small volume of 6 M guanidineHCl, 1 M HEPES, at pH 6.9. As the histone cysteine forms a disulfide bond with Ubaminoethanethiol, TNP is again released. Within minutes the solution becomes neon
yellow. After 10 minutes the reaction was stopped with 0.1% TFA. H2AssUb and
H2BssUb formed in this reaction were purified by semi-preparative C18 RP-HPLC, using
a 35-65% B gradient.

xlH2Bub(G76A) preparation
“Nearly native” xlH2Bub(G76A) histone and octamers were prepared by Dr. Rob
McGinty as previously described (McGinty et al., 2008).

Dimer, tetramer, and octamer preparation from human histones
For this study, four types of human histone dimers were assembled: H2A/H2B,
H2AssUb/H2B, H2A/H2BssUb, H2AssUb/H2BssUb. In equal molar amounts, purified
histones were combined at approximately 2 mg/mL in denaturing buffer [50 mM MOPS
pH 7, 6 M guanidine-HCl, 20% glycerol, 5 mM EDTA] and dialyzed overnight into
refolding buffer [10 mM MOPS pH 7, 500 mM NaCl, 10% glycerol, 0.5 mM EDTA]
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using dialysis buttons from Hampton Research. To remove insoluble material, samples
were spun at 16,100 x g for 30 min at 4 degrees.
For the human octamers used in this study, only unmodified H3/H4 tetramers
were needed. Consequently, these were assembled and purified on a large scale, allowing
all human octamers prepared to contain the same source of H3. These H3/H4 tetramers
were assembled as described above for H2A/H2B dimers, and purified by size exclusion
chromatography. Briefly, after clearing the tetramer assembly with a 30 min spin at
16,100 x g, tetramers were concentrated to 10-15 mg/mL with Amicon Ultra centrifugal
concentrators (Millipore). Size exclusion chromatography was performed on an ÄKTA
FPLC with a HiLoad 16/600 Superdex 200 column (GE Healthcare) in refolding buffer.
Fractions from the peak corresponding to H3/H4 tetramers were pooled and stored at -20
degrees in 50% glycerol.
Unmodified, H2AssUb, H2BssUb, and H2AssUb/H2BssUb octamers were
assembled by mixing purified tetramers and dimers in refolding buffer and dialyzing
them into high salt buffer [10 mM MOPS pH 7, 2 M NaCl, 10% glycerol]. Because
tetramers are difficult to purify away from octamers using Superdex 200 columns,
octamer assemblies were set up with a slight excess of dimer relative to tetramer (e.g. 2.2
moles H2A/H2B dimer : 1 mole H3/H4 tetramer). After clearing octamer assemblies with
a 30 min spin at 16,100 x g, they were concentrated to 5-10 mg/mL and purified by size
exclusion on a Superdex 200 10/300 GL (GE Healthcare) in high salt buffer. Pooled
octamer fractions were stored at -20 degrees in 50% glycerol.
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Nucleosome positioning sequence preparation and purification
DNA fragments for mononucleosome assemblies were prepared by EcoRV
restriction digest of 32x153bp tandem repeats of the 601-positioning sequence(Lowary
and Widom, 1998) cloned into pUC19 (a kind gift from Kyle Chiang). After checking by
agarose gel electrophoresis that the digest was complete (only 153bp fragments and ~3kb
plasmid backbone fragment), 153bp DNA fragments were purified by plasmid backbone
precipitation in 500 mM NaCl with 7.5% polyethylene glycol (PEG-6000) on ice for
several hours. The soluble DNA fragments were then further purified away from EcoRV
protein with several rounds of Phenol/Chloroform extraction and finally ethanol
precipitated. Starting with 1 mg of plasmid DNA, the expected yield of purified 153bp
601-positioning sequence is about 400 µg (4.25 nmoles).

Mononucleosome preparation
Gradient dialysis was used to assemble mononucleosomes from octamers and
positioning sequence DNA. Approximately equal molar amounts of purified octamers
and 153bp DNA were brought to 0.7 mg/mL DNA in high salt buffer (see octamer
preparation method). Starting in 1 volume high salt buffer, a peristaltic pump was used to
add zero salt buffer [10 mM Tris pH 7.5, 1 mM EDTA] drop-wise over ~24 hours to a
final volume of 10 volumes. Completed assemblies were cleared with a spin at 16,100 x g
and visualized on a native 5% polyacrylamide gel, stained with ethidium bromide.
Because the precise octamer to DNA ratio is crucial to obtain assemblies with little or no
free 153bp DNA and efficient incorporation of octamers into nucleosomes, small scale
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trial assemblies were performed with each batch of purified octamer to determine the
optimal measured octamer : DNA ratio.

Endogenous nucleosome purification from HeLa cells
Native nucleosomes were solubilized from HeLa cells with micrococcal nuclease
(MNase) and purified by ultracentrifugation on sucrose gradients, essentially as
previously described (Fang et al., 2004). Briefly, 4-5L of HeLa S3 cells were grown in
spinner culture at ~ 1.5 x 106 cells/mL. Cell pellets were washed with PBS and
resuspended at ~ 2.5 x 107 cells/mL in N1 buffer [10 mM MES, 5 mM MgCl2, 1 mM
CaCl2, 15 mM NaCl, 60 mM KCl, 0.25M sucrose, 0.5% Triton X-100, 0.5 mM DTT, pH
7.5] supplemented with 0.1 mM PMSF, 0.5 mM sodium metabisulfite, and 0.5 mM
benzamidine-HCl. In this buffer, gentle douncing is sufficient to lyse cells, and pelleted
nuclei were washed once with N1 before being resuspended at ~ 8 x 108 starting cells/mL
in buffer N2 [10 mM PIPES, 5 mM MgCl2, 1 mM CaCl2, pH 6.5] supplemented with 0.1
mM PMSF, 0.5 mM sodium metabisulfite, and 0.5 mM benzamidine-HCl. While leaving
the bulk nuclei on ice, a small aliquot (~ 500 µL) was used for trail MNase digests, with
the appropriate digestion time determined by 1% agarose gel electrophoresis of MNase
solubilized DNA.
After determining digestion conditions, the bulk nuclei were warmed to 37
degrees, and CaCl2 was raised to 5 mM. Digestion at 37 degrees was started by adding ~
1U Worthington MNase per 10µL nuclei suspension and stopped by adding EDTA to
20mM. Solublized chromatin (S1) was separated from insoluble and nuclear debris by a
10 min spin at 3,000 x g. To solubilize very long chromatin fragments (S2), pellets were
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vortexed in 1 pellet volume [1 mM EDTA, 0.2 mM PMSF], rested on ice for 15 min, and
then cleared with a 15 min spin at 12,000 x g. S1 and S2 were pooled and NaCl was
brought to 750 mM by adding 5 M dropwise. This elevated salt concentration strips most
chromatin-associated proteins off nucleosomes, including H1.
32 mL sucrose gradients in NG buffer [10 mM Tris-Cl, 1 mM EDTA, 750 mM
NaCl, 0.3 mM PMSF] were prepared in polyallomer tubes with a binary gradient mixing
machine, using 5% sucrose/NG and 30% sucrose/NG solutions. After carefully applying
~ 3 mL of the MNase soluble sample on top of each gradient, fractionation was
performed by ultracentrifugation for 16 hours at 26,000 rpm in a SW28 rotor. 1 mL
fractions were taken from the top of each gradient. Fractions containing minimal nonhistone proteins were pooled. If mononucleosomes were desired, a fraction of this pool
was dialyzed out of EDTA and digested again with MNase, although this time with ~
1/10 as much enzyme. All nucleosome pools were further purified by an addition passage
over 5-30% sucrose gradients. Final pooling decisions were based on DNA fragment
sizes as assessed by 1% agarose gel electrophoresis and EtBr staining. Final fraction
pools were concentrated (Amicon Ultra) to ~ 200 ng DNA/µL, dialysed into HSB [10
mM Tris pH 7.5, 10 mM NaCl, 1 mM EDTA, 10% glycerol, 0.2 mM PMSF], and stored
at -80 degrees.

Dot1L methyltransferase assays
Flag-hDot1L was purified from a baculovirus expression system as previously
described (McGinty et al., 2009a; McGinty et al., 2008). In each methyltransferase assay,
4.1 pmoles of mononucleosomes, 0.14 pmoles of Flag-hDot1L and 15 pmoles 3H-SAM
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(1 µCi 3H) were combined in 12 mL at 20mM Tris pH 8.0, 10 mM NaCl, 5 mM MgCl2, 1
mM EDTA. Reactions were allowed to proceed for 75 min at 30 degrees and activity was
assessed by fluorography and/or scintillation counting. For fluorography, a fraction of
each reaction samples was run on 4-20% Tris-Glycine SDS-PAGE gels. Note that
NuPAGE precast gels from Invitrogen reduce the disulfide bond between ubiquitin and
histone H2AK119C and H2BK120C, and therefore are not appropriate for however,
precast gradient TGX gels from Bio-Rad do not. The gel was Coomassie stained,
amplified with Amersham fluorographic reagent, vacuum dried and exposed to film for
12 hours -5 days. For scintillation counting, a fraction of each reaction spotted onto
Whatman p81 filter paper, air-dried, washed 3x10 min in 100 mM NaHCO3 and then
quickly in acetone. Washed and air-dried filter papers were immersed in Scintillation
cocktail (Perkin-Elmer) and scintillation counted.

PRC2 methyltransferase assays
Recombinant PRC2 complex [Ezh2, Flag-Eed3, Suz12, RbAP48] was purified
using a baculovirus expression system as previously described(Cao and Zhang, 2004). In
a typical methyltransferase assay, 200 ng nucleosomal DNA, 20 ng Ezh2 in PRC2
complex, 15 pmoles 3H-SAM (1 mCi 3H) were combined in 12 mL reactions at 20mM
Tris pH 8.0, 10 mM NaCl, 2.5 mM MgCl2, 1 mM EDTA, 0.5 mM DTT. Reactions were
carried out at 30 degrees and activity was assessed by fluorography and/or scintillation
counting as described for Dot1L methyltransferase assays above.
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In vitro enzymatic ubiquitylation of H2A
Recombinant Ring1B-6xHis and GST-Bmi1 were co-expressed in E. coli and
tandem-affinity purified. In a typical in vitro ubiquitylation reaction, 600 ng nucleosomal
DNA, 600 ng Ring1B/Bmi1 complex, 1 ug ubiquitin (BostonBiochem), 50 nM 6xHisUBE1 (BostonBiochem), 3 µM UbcH5c (BostonBiochem), and 4 mM ATP-Mg (Sigma)
were combined in a 20 µL reactions in 20mM Tris pH 8.0, 10 mM NaCl, 2 mM MgCl2, 1
mM EDTA, 0.5 mM DTT. Reactions were carried out at 37 degrees for 45-60 minutes,
stopped with Laemmli sample buffer. Ubiquitylation activity was assessed by western
blotting.

Mass Spectrometry analysis of in vitro enzymatic ubiquitylation reactions
Mass Spectrometry analysis was performed by Joe Fernandez, The Rockefeller
University Proteomics Resource Center.

Antibodies
The following antibodies were used in this study: anti-H2A (Millipore, # 07-146),
anti-H2B (Proteintech, ptglab.com, rabbit polyclonal raised against full-length Xenopus
laevis histone H2B), anti-H2AK119ub (Nakagawa et al., 2008 (Nakagawa et al., 2008)),
anti-H2BK120ub (Cell Signaling Technology, #5546).
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